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1. CHAPTER ONE: INTRODUCTION 
 
 
1.1 Background  
 
About 2.4 billion people worldwide are at risk of malaria, most of them in developing 
countries. Although countries have had mixed results in malaria control, the World 
Health Organisation (WHO) malaria report of 2008, observed that the decade 1997 – 
2006 has seen significant reduction in malaria burden by at least 50% in 22 WHO 
region countries in the Americas, the South- East Asia and Western Pacific 
regions(WHO, 2008). The reduction has been due to multiple malaria control policies 
including use of Insecticide Treated Nets (ITNs) and use of Artemisinin-based 
Combination Therapies (ACT) as 1
st
-line treatment for uncomplicated malaria. In 
Africa, only four countries (Eritrea, Rwanda, Sao Tome and Principe, and Zanzibar 
(part of Tanzania) have convincing evidence of a reduction in malaria burden by up to 
50% during the same decade (1997 – 2006) (WHO, 2008). Although Kenya has not 
experienced a 50% overall reduction in malaria burden, case studies have provided 
evidence of declines in morbidity and mortality (Noor et al., 2009, Okiro et al., 2009, 
Snow et al., 2009). The paediatric hospitalization for malaria in 17 hospitals across 
Kenya, for instance, reported a reduction of up to 49% (Okiro et al., 2009). 
The need to sustain gains in the fight against malaria has seen Kenya and many 
countries in Africa changing 1
st
 line treatment policy for uncomplicated malaria from 
sulfadoxine-pyremethamine (SP) to the more potent ACTs. Around 2001/2002 
resistance to SP was common-place. The WHO reacted by strongly urging countries 
that intended to change their malaria treatment policies to adopt the ACTs as the best 
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Kenya changed from SP to ACT in 2004, marking the second policy change for 1
st
-
line drugs in the country since independence 46 years ago. The first change in the 
malaria treatment policy involved a move from chloroquine (CQ) to SP in 1998. Each 
change in the 1
st
-line treatment policies for uncomplicated malaria involved revision 
of malaria treatment guidelines. The type of ACT used in Kenya is Artemether-
Lumefantrine (AL) that trades by the name Coartem. The actual roll-out for AL began 
in late 2006 (Amin et al., 2007). The regimen for AL involves two doses per day for 
three days with an eight to 12 hour-break between each dose. Instructions to health 
workers on how and when to administer AL were documented in the new treatment 
guidelines for malaria. SP on the other hand, had only three tablets for adults, all 
taken in one dose.   
 
The United States Agency for International Development (USAID) noted that 
changing and implementing drug policies are complex and fraught with challenges at 
every level. The challenges range from stakeholders‟ interests, local and international 
bureaucracy (USAID, 2005), to the potential resistance from the intended 
beneficiaries. In Kenya, despite the change from SP to AL, much remains to be done 
in malaria control. The task ahead does involves sustaining the declining malaria 
burden while also ensuring proper take-up of AL. Uptake of AL in Kenya is said to be 
below expectations (Wasunna et al., 2008). The uptake of health interventions can be 
improved with the involvement of the community (Muga and Jenkins, 2008). The 
involvement of the community is important because people tend to have negative 
perceptions about drug policy changes. These perceptions are driven significantly by 
illiteracy, misinformation and cultural beliefs (Williams et al., 1999, Lettenmaier, 
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perceptions. This explains why communication strategies become an integral part of a 
drug policy change. Passing the right information through appropriate communication 
channels helps to influence community perceptions and treatment seeking behaviour 
and has a positive impact on the implementation of the policy (Hausmann-Muela et 
al., 2003, Lettenmaier, 2003). What the public believes about the (treatment) policy 
change and why the policies change can influence treatment seeking behaviour. The 
behaviour can also be influenced by the perceived effects of the change and people‟s 
perceptions about the  effectiveness of the new treatment policy (Muga and Jenkins, 
2008). Ideally, a change in policy in 1
st
-line treatment should be followed by 
corresponding changes in certain aspects of treatment seeking and hence the desired 
uptake of the new policy. The results of the change are likely to depend on how 
effectively the policy change is communicated and understood by the public. In 
Kenya, the Information, Education and Communication (IEC) strategies 
accompanying change of 1
st
-line treatment policy from SP to AL involved multi-
media approaches but it is not clear whether the communication that was directed at 
the public achieved the desired objectives. 
 
1.2 Problem Statement 
 
 
The problems of non-adherence to recommended malaria dosage and the use of 
ineffective malaria drugs is most common in poor rural areas (Attaran et al., 2004). 
These are key catalysts in development of drug resistance. Although changing 1
st
-line 
drugs for uncomplicated malaria in response to resistance is scientifically appropriate, 
it is not clear whether the public usually is adequately prepared for the changes, 
whether it (the public) understands the purpose and reason for drug policy changes, 
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new drug policies requires effective communication strategies to forestall resistance 
from the community (Lettenmaier, 2003). These strategies are meant to ensure the 
public is informed of the change and to educate people on the need to adapt to the 
recommended drugs (Lettenmaier, 2003). However, it is not clear the extent to which 
communication strategies do influence public perceptions, expectations and use of 
recommended drugs. For these reasons, it is necessary to investigate community 
responses to drug policy changes and how the responses influence uptake of 1
st
-line 
treatment for uncomplicated malaria drugs, in this case, AL.  
   
1.3 Research Questions 
 
 
The study addresses two main questions: (i) How do rural communities perceive 
policy changes on 1
st
 line drugs for uncomplicated malaria in Kenya? (ii) How are the 
perceptions influenced by policy communication strategies?  
Specifically, this study sought to answer the following questions:  
1. What do communities understand about the policy changes on 1st-line drugs for 
uncomplicated malaria in Kenya? 
2. What is the potential influence of communication strategies for the policy change 
on the community experiences? 
3. What implications does the study have for future drug policy changes and 
communication strategies? 
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The study aims to contribute to malaria control efforts by analysing gaps in policy 
communication at the community level and making suggestions on future strategies in 
policy communication.  
 
1.4.2 General Objective 
 
 
To explore community perceptions of policy changes on 1
st
-line drugs for 
uncomplicated malaria in Kenya and the potential influence of communication 
strategies on use of recommended drugs. 
 
1.4.3 Specific objectives 
 
 
1. To explore community understanding of successive policy changes on 1st-line 
drugs for uncomplicated malaria in Kenya;  
2. To evaluate the potential role of communication strategies in 1st-line drug policy 
changes in influencing community responses to these changes; 




This study intends to give new insights into community perceptions on policy changes 
in 1
st
-line treatment for uncomplicated malaria in Kenya and the contributions of such 
perceptions on the uptake of recommended malaria drugs. It also intends to promote 
effective communication and implementation of malaria treatment policies and 
highlight public concerns about drug policy changes, and finally, add to the literature 
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1.6 Outline of remaining chapters 
 
 
Chapter Two reviews relevant literature; Chapter Three presents the methods of the 
study; Chapter Four has findings that are grouped into relevant sub-headings, and 
Chapter Five has analysis and discussions of study findings. The same chapter also 
concludes the study and gives recommendations in line with the findings. The 
literature review identifies studies that support the topic under consideration, apart 
from identifying the gaps that this study sought to fill. As there are no studies that 
have specifically looked at community perceptions about drug policy changes, a wide 
range of material was used  covering health seeking behaviour, perceptions of health 
interventions especially drugs, and policy  communication. The methodology chapter 
gives details on how the study progressed; for example, justification of methods, how 
data were collected and analysed, and the rigour of the study.  Chapter Four presents 
the overall outcomes of the study as well as explaining the reasons for the outcomes. 
Chapter 5 presents an analysis and discussions of the findings in relation to the 
existing literature in the field. The chapter concludes with key points and draws out 
recommendations from the experiences gathered in order to strengthen future 
communication on policy changes for 1
st
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This review is based on a systematic search for published and unpublished literature 
relevant to the study, using various strategies including PubMed search, Google 
search and Google scholar search, as well as sourcing literature from web-pages for 
internationally reputable institutions such as the WHO and Institute for Development 
Studies (IDS),  United Kingdom. Apart from perceptions on new drugs and other 
health interventions such as immunisation, few studies have paid attention to what the 
public understands of policy changes on 1
st
-line treatment for uncomplicated malaria. 
As such there is limited explicit literature addressing the topic under study. As a 
result, the review had to use various phrases to locate literature that was closely 
related to the subject under study.  
 
The following key phrases were used to search for relevant literature: ´policy change 
communication‟; „folk beliefs treatment seeking‟; „community perceptions drug policy 
changes‟ „malaria policy; „challenges drug policy change‟; „community drugs 
policy‟; health policy implementation; policy AND communication. A phrase such as 
„folk beliefs treatment seeking‟ was selected because treatment seeking behaviour has 
a direct influence on people‟s reactions to a policy change that introduces a new drug 
into the health system. A new drug is supposed to alter some aspects of treatment 
seeking. „Policy change communication‟ was selected on the basis that new policies 
need to be communicated to the wider public and the effectiveness of the 
communication could empower the public with the information that they need to 
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because they were likely to come up with literature that bordered on community views 
over a range of health-related interventions that could have been relevant to the study. 
Literature that was identified included peer reviewed journal articles, books, theses, 
unpublished literature reviews and conference/workshop presentations.  All the 
accruing documents were examined and those regarded as relevant to the study were 
taken for review. Materials were excluded on the basis that, first, they were not related 
to responses to policy changes of any nature, and second, they were not relevant to 
communication in health or health education. Given the material finally reviewed, this 
chapter is structured under three broad sub-headings: (i) Treatment seeking behaviour, 
(ii) Public perceptions on health interventions and (iii) Role of communication in 
malaria drug policy changes.  
 
2.2 Treatment seeking behaviour 
 
 
Policy changes that seek to introduce new drugs into the health system to replace 
ineffective ones need to consider people‟s treatment seeking behaviours because the 
behaviours may influence acceptance of new interventions (Mwenesi et al., 1995, 
Hausmann-Muela et al., 2003). A successful drug policy change should significantly 
alter treatment seeking behaviour to enhance uptake of newly introduced drugs. 
Considerable success could be registered in this regard with provision of adequate 
information through the right channels for the public (Hausmann-Muela et al., 2003). 
Established behaviours are difficult to change because people tend to go for drugs that 
they are familiar with rather than use the newly recommended ones (Mwenesi et al., 
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Cultural beliefs and attitudes are also likely to underpin resistance to new changes in 
treatment and limit uptake of new drugs (Mwenesi et al., 1995, Eriksen et al., 2005). 
Various cultures have varied interpretations of the causes and treatment of illnesses 
(Mwenesi et al., 1995, Eriksen et al., 2005). Malaria, for example, presents with a 
variety of symptoms and is subject to various interpretations across cultures. In some 
cultures, malaria is caused by evil spirits that can only be treated by traditional 
healers. In other cultures, it is caused by hot sun and cold water (McCombie, 2002). 
These meanings of disease influence the timing and type of treatment sought. 
Accordingly, understanding people‟s views on malaria, its causes and the available 
treatment choices is important if successful policy changes are to be realised 
(McCombie, 2002, Mbonye et al., 2006b). Implementation of health policies depends 
on how compatible the policies are with the public‟s concepts regarding specific 
health problems (Muga and Jenkins, 2008). The use of bed-nets typifies the problems 
of compatibility between a health policy and the public. Despite their efficacy against 
malaria infection, the use of mosquito nets remains quite low in some places (Chuma 
et al., 2010). A useful explanation to this trend would be people‟s perceptions about 
the dangers of malaria, attitudes and cultural aversion to use of nets (Lettenmaier, 
2003, Alaii et al., 2003b). 
 
In some cases, in defining a disease category, a patient‟s characteristics and social 
situation are considered more than signs and symptoms (McCombie, 1996). For 
instance, joint-aches may not be immediately recognised as a symptom for malaria, 
but it may be associated with carrying heavy loads or hard work. This delays 
treatment seeking mainly because there is neither specific symptom category for 
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1996).  Sometimes the characterisation of disease is dictated by cultural 
interpretations of illness whereby certain symptoms trigger specific actions regardless 
of the nature of illness and its appropriate treatment (Hausmann-Muela et al., 2003). 
The authors give an example of the cultural concept of degedege in Tanzania, whose 
symptoms include convulsions. The convulsions, to most people without biomedical 
knowledge, should be treated traditionally. Among people with biomedical 
knowledge, traditional treatment is often taken alongside modern methods where 
degedege applies (Hausmann-Muela et al., 2003). In some other cultures, the 
perception of severity of an illness is often associated with use of the official sector    
(Mbonye et al., 2006b, Mbonye et al., 2006a, Mbonye et al., 2006c). But the 
community definitions of severity are not always the same as health worker‟s 
definitions. Therefore, seriously ill cases may not be immediately taken to health 
facilities and vice-versa. Other factors that may affect treatment seeking are health 
system-based. For example, in the sub-Saharan Africa 40% of fevers are attributable 
to malaria, and in health facilities where diagnostic kits are lacking the main strategy 
to control morbidity and mortality is presumptive treatment (McCombie, 2002, 
Mbonye et al., 2006b, Mbonye et al., 2006a, Mbonye et al., 2006c). The success of 
this kind of approach to treatment depends a lot on the behaviour of patients and care-
takers especially with regards to drug adherence (McCombie, 2002). 
 
Treatment seeking behaviour for malaria may be grouped into three categories: self-
treatment, the formal health sector and use of traditional medicines and healers 
(Mwenesi et al., 1995, McCombie, 1996, Mbonye et al., 2006c). Each of these 
categories may be used exclusively but they are also often used successively; one after 
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one option after another as illness progresses (Mbonye et al., 2006b). For those who 
opt for self-treatment at home, it is not always clear what kind of drugs they use and 
the dosage consumed, and these have implications on drug resistance (McCombie, 
2002). Most of the drugs bought from retail shops for self-treatment are either 
ineffective anti-malarials or none at all (Ruebush et al., 1995, McCombie, 2002, 
Mbonye et al., 2006c, Mushi et al., 2008). Inappropriate use of drugs could lead to 
fatal outcomes or may involve alternative costly treatment from worsening illness that 
should have been avoided. Such poor approaches to malaria treatment often lead to 
drug resistance (Attaran et al., 2004). Fatal outcomes or worsening cases of malaria 
are not only the result of use of ineffective drugs, but also people‟s attitudes towards 
particular drugs and delays in seeking treatment (Mwenesi et al., 1995). The delay 
may be caused by high cost of medicine, travel or time lost from work as well as 
difficulty in accessing the formal sector (Mwenesi et al., 1995, McCombie, 2002, 
Attaran et al., 2004)  
 
While there are a wide variety of malaria drugs in both formal and informal sectors, 
there are concerns that the drugs are often used inappropriately, especially in the 
informal sector (Attaran et al., 2004). The incorrect use of drugs is mainly associated 
with lack of appropriate knowledge and information on the right dosage. The most 
affected by the inappropriate use of drugs from the informal sector are the hard-to-
reach rural populations. People often buy ineffective drugs from shops even if there 
are better anti-malarials at formal health facilities that are either free or at a much 
lower cost compared to what is paid for at the shops. The reasons for this kind of 
behaviour include distance to facilities, personal preference for drugs from the shops, 
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2005, Mushi et al., 2008). The other major reason responsible for consumption of 
drugs from the informal sector is drug shortages at health facilities (McCombie, 2002, 
Mubyazi et al., 2005, Rutebemberwa et al., 2009). 
 
About 70 to 80% of malaria cases are treated outside the formal health system 
(McCombie, 2002). In Kenya, less than 50% of drugs bought from shops are effective 
anti-malarials (McCombie, 2002). To address problems associated with self-
treatment, small-scale community-based drug dispensing policies were initiated in 
Kenya under the essential drugs package. The initiatives attempted to reduce impact 
of malaria by promoting community distribution of chloroquine. One such initiative 
was carried out in Saradidi, a Kenyan village, where drug distribution points were 
established at strategic places like markets and people made aware of them. Although 
the initiative  changed the source of treatment, it had no impact on mortality, a factor 
associated with high resistance to CQ at the time (McCombie, 1996).  
 
The misuse of pharmaceuticals has aggravated the problem of drug resistance (Attaran 
et al., 2004) and this has necessitated changes in 1
st
-line treatment for uncomplicated 
malaria in endemic countries. Even though countries change policies on the 1
st
-line 
treatment for uncomplicated malaria on account of drug resistance, people continue to 
use outdated drugs like Chloroquine (CQ) and SP. This could be linked to lack of 
knowledge and information among users (Mushi et al., 2008). The lack of knowledge 
and information encompasses many aspects of treatment seeking including the 
perception that CQ and SP are still efficacious and the perception that a bitter or high 
cost drug is more effective than others (Rutebemberwa et al., 2009). Other reasons 











18 | P a g e  
 
over side-effects and use of the drug over-time (Rutebemberwa et al., 2009). CQ 
owed its popularity to low cost, safety and easy availability from kiosks, shops and 
drug stores (McCombie, 2002, Mubyazi et al., 2005). However, continued availability 
of these mostly ineffective drugs is a result of flawed policies pursued by the WHO 
and the Global Fund for HIV/AIDS, Tuberculosis and Malaria (GFATM) (Attaran et 
al., 2004).  
 
The medicines in the informal sector is highly heterogeneous, but there are concerns 
over the quality of treatment and drugs (Bosman and Mendis, 2007). Kenya for 
instance, has about 218 brands of registered anti-malarial products. These keep the 
market confusing and supports continued consumption of  non-recommended brands 
including artemisinin monotherapies (Bosman and Mendis, 2007). The availability of 
many types of malaria drugs in the market may be good for individual preferences 
because of the tendency to prefer one drug over another, but the diversity is only good 
as long as the drugs are effective (Bosman and Mendis, 2007). The fact that there are 
many ineffective anti-malarials being consumed by an unknowing public is 
exploitative to the consumers who have to spend scarce resources on products that 
cannot cure them. It is the responsibility of the government to maintain quality in the 
market. The Kenya government has made a commitment to withdraw marketing 
authorisation for artemisinin monotherapies (Bloland et al., 2000), but there are no 
follow-up studies on progress made so far.  
 
2.3 Public perceptions about health interventions 
What the public understands with a health intervention may influence how people 
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chances of successful implementation and uptake are often limited. Bed-nets for 
example, have sometimes met considerable resistance, especially in rural areas, 
because of negative perceptions that communities have about them (McCombie, 2002, 
Alaii et al., 2003a, Alaii et al., 2003b). The fact that community resistance lingers 
long after Insecticide Treated Nets (ITNs) were introduced may have contributed to 
the reported low usage of ITNs (Gilson L, 2008.). This means any policies that 
introduce mass distribution of bed-nets where negative community sentiments against 
ITNs persist, may not make significant progress in malaria control.   
 
Health worker perceptions about an intervention do not always influence the 
responses of beneficiaries towards the intervention. This has been shown in a study of 
perceptions of health workers about use of AL in four Kenyan districts (Wasunna et 
al., 2008). The study indicated that health workers had positive views of AL although 
the use of the drug among the beneficiaries remains below average (Wasunna et al., 
2008). The subject of health worker attitudes regarding an intervention and how 
beneficiaries respond to the intervention based on health worker attitudes has not been 
fully documented. Health worker practices such as dispensing AQ or SP instead of 
AL, if influenced by negative perceptions of AL at all, may directly influence how the 
larger community would view and respond to AL.  
 
In many cases, rumours and misconceptions about changes in drug policies may affect 
uptake of recommended drugs (Lettenmaier, 2003). The rumours and misconceptions 
may include issues such as new drugs being part of feasibility test on human beings or 
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Perceptions about a new drug could also reflect on how beneficiaries and 
implementers view treatment policy changes. There is scant literature in this regard.  
A key issue from the literature is that user perceptions should be compatible with the 
intentions of a new health intervention if successful implementation is to be realised 
(Muga and Jenkins, 2008). It means that treatment policies, which are meant to ensure 
better treatment of malaria and hence contribute to disease control, should be known 
to the beneficiaries. Contradicting views of the beneficiaries can make 
implementation of the new policy difficult. Even with  the commitment of health 
workers and the funders, a new policy will be difficult to implement if it is 
unacceptable to  the public (Muga and Jenkins, 2008).  Malaria control is primarily a 
community issue (Ghosh et al., 2006) but most often policy beneficiaries feel that they 
have no role in malaria control, more-so when they are left out of the policies that are 
geared towards control of the disease (Opiyo et al., 2007).  When people are excluded 
from drug policy changes during implementation, they will most likely be unaware of 
the policy goals or intentions. Such situations may give room for the community to 
create their own conceptions about newly introduced drugs because their concerns 
may not have been addressed during implementation (Hausmann-Muela et al., 2003).  
 
Some studies have already documented how the public responded to the introduction 
of new drugs into the health system (Williams et al., 1999). The responses may result 
from cultural concepts of malaria causation and treatment, lack of biomedical 
knowledge and poor knowledge of the new drug. In Zambia, community concerns 
about the change from CQ to SP were about efficacy of SP because it had fewer 
tablets compared to CQ that had 10 tablets (Williams et al., 1999). In Uganda a bitter 
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et al., 2009). A bitter anti-malarial was viewed by the community as more effective 
than a sweet one. Such concerns may in turn generate distrust or lack of confidence in 
health care provision (Williams et al., 1999, Gilson, 2007), particularly in cases where 
a new treatment policy replaces a bitter drug with one that is not.  
 
Health systems that are not culturally sensitive have contributed to misconceptions 
about new drugs (Gilson, 2007). Such are health systems that fail to account for the 
local concepts of disease and what influences treatment seeking behaviour. Culturally 
inappropriate health systems may create communication barriers between patients and 
providers leading to poor information provision and mistrust of health care providers 
(Gilson, 2007, Mwisongo, 2007).  Sometimes the reluctance to change to a new 
treatment policy can result from usage of specific drugs over time and misinformation 
(Rutebemberwa et al., 2009). With the introduction of SP into the Tanzanian health 
system, beneficiaries associated SP with an experiment that the government was 
carrying out on the public (Eriksen et al., 2005). Responses to a new treatment policy 
that are informed by local culture, ignorance or inadequate information are sometimes 
negative and could limit successful implementation of the new policy. The 
introduction of SP in Tanzania made communities to believe that SP posed some 
health problems to users including possibilities of miscarriage and death, growth of a 
large baby that could pose problems during delivery and making patients weak 
because of its perceived strength (Eriksen et al., 2005, Mbonye et al., 2006b).  
 
In some cases, it is the medical prerequisites on the use of a drug that discourages 
patients from using it. For example, when patients were advised by health workers to 
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drug must be too strong (Mbonye et al., 2006b). Such a perception can have a direct 
negative influence on the uptake of a new treatment policy yet it is avoidable if health 
workers take time to explain to patients why SP needed to be taken with fluids. 
Hence, poor communication between providers and patients can inadvertently and 
directly act as a barrier to use of new interventions (Mbonye et al., 2006b). The need 
to use fluids also had cost implications that posed more barriers to the use of SP. 
Other barriers to the use of new treatment interventions have been linked to poor 
market regulation that has failed to curb proliferation of the largely ineffective anti-
malarials (Mbonye et al., 2006b, Bosman and Mendis, 2007). The cheap and 
widespread availability of the ineffective anti-malarials encourages self-treatment 
instead of seeking effective treatment from formal health facilities.    
 
A large number of people, especially in the rural areas, continue to use old drugs 
because of their doubts about efficacy of new drugs and the fear that new drugs could 
be dangerous (Nsimba, 2006a). Many of these negative observations are informed by 
illiteracy and misinformation (Nsimba, 2006a). In other contexts, persistent use of 
drugs increases the possibility that they will be viewed positively among community 
members (Eriksen et al., 2005, Rutebemberwa et al., 2009). For instance, chloroquine 
was perceived as the best drug whose efficacy was not in doubt (McCombie, 2002, 
Nsimba, 2006a). This contributes to persistent demand for non-efficacious drugs even 
after treatment policies have changed.  
 
Not all public perceptions are always negative. Positive views by communities over 
health interventions are defined from cultural understandings and associations and can 











23 | P a g e  
 
of SP tablets were perceived to be for making the mother and unborn child healthy, 
particularly to protect them from malaria (Eriksen et al., 2005). Community 
receptivity to immunisation policies in West Africa also revealed immunisation was 
viewed positively as giving strength to children by introducing a powerful substance 
into the blood to protect against illnesses (Leach and Fairhead, 2008). This logic is 
applied to all forms of diseases and not only that against which a child is immunised. 
The strength goes beyond the limits of the individual person immunised to encompass 
whole communities and regions (Leach and Fairhead, 2008). Hence, the desire for 
strength and power by a community may drive demand for immunisation. These local 
social and cultural perspectives need to be understood in order to address challenges 
that come with implementation of health policies (Leach and Fairhead, 2008).  
 
To address misconceptions among beneficiaries against a new treatment policy, 
various strategies should be employed that are aimed at behaviour change (Malik et 
al., 2006). Such strategies should involve well researched evidence, proper 
communication, donor support, national and regional approaches and a better 
understanding of the political system (Williams et al., 1999, Malik et al., 2006). The 
input of beneficiaries, particularly their perceptions of the new policy, should then be 
considered as equally important. Also important to policy implementation is the 
context; for instance, where there are too many anti-malarials, attitudes emanating 
from ease of access may hinder uptake of new drug policies (Williams et al., 1999, 
Malik et al., 2006) because of public familiarity with the old drug (Eriksen et al., 
2005).   
To ensure successful implementation and avoid resistance from beneficiaries, a policy 
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actors. Key actors  should be involved in policy making and implementation (Walt 
and Gilson, 1994). The key actors in health policy making may include public 
agencies, the private market sector, consumers, regulatory agencies, the scientific 
community and politicians, who interact to influence policy implementation 
(Williams and Jones, 2004). Importantly, policy implementation needs to take account 
of the views and expectations of beneficiaries as well as other actors (Gilson and 
Erasmus, 2006). The common top-down approach to policy implementation rarely 
considers the ways in which actors at the „bottom‟, such as front line health workers 
and beneficiaries, always influence policy implementation success (Gilson and 
Erasmus, 2006). As a result, drug policy changes may face resistance from 
beneficiaries during implementation, because community misunderstandings about 
the new policy may not have been adequately addressed.  
 
2.4 Role of communication in policy change 
 
The WHO recognizes equitable and universal access to health information as vital in 
strategies aimed at reducing global inequities in health and in achieving the health-
related Millennium Development Goals (Godlee et al., 2004). Achieving the goal of 
Universal access to essential health-care information by 2015 would be essential in 
enhancing health outcomes. The problem with low- and middle-income countries is 
lack of access to health information, which is a major hindrance to knowledge-based 
health care (Godlee et al., 2004). Although access to information is necessary, it alone 
cannot change behaviours and practices. Other factors also need to be considered 
including use of information, awareness of what is available, relevance of available 
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information, and interpretation skills to understand the health messages being passed 
(Godlee et al., 2004).  
 
The strategies used to pass health information should consider a community‟s 
preferred channels of information delivery as this increases access to the messages 
being passed (Eng et al., 1998, Kreuter and McClure, 2004, Claasen-Veldsman and 
Snyman, 2005). To improve access to information, two dimensions should be 
considered: physical access ensures that information is available and within reach. 
Semantic/linguistic access is the ability of the audience to understand the meaning of 
the message (Claasen-Veldsman and Snyman, 2005, Eng et al., 1998, Kreuter and 
McClure, 2004). Increasing access to information should use linguistic strategies that 
provide health information in the dominant or local languages of the target audiences.  
These strategies make health communication campaigns, programs, and materials 
readily available to the intended beneficiaries (Kreuter and McClure, 2004). Language 
being fundamental to effective communication, renders linguistic accessibility as the 
most basic in terms of cultural sensitivity (Kreuter and McClure, 2004). Affordability 
of information sources is also considered as an important aspect of access to health 
information (Emmanuel, undated). Improved access to appropriate health information 
impacts positively on the quality of health care, apart from supporting public health 
goals (Eng et al., 1998). Availability of health information is a public health good, 
which forms part of a chain of factors with influence on the adoption of healthy 
behaviours and disease prevention  (Eng et al., 1998).  
 
The medium through which information is passed determines effectiveness of 
communication. This requires that the audience, the message and the medium be in 
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most of Africa are characterised by poor access to health information and low literacy 
yet a lot of information has pro-literacy bias (Claasen-Veldsman and Snyman, 2005). 
A print medium for a low literacy audience, for example, is ineffective in as much as 
information passed through the radio for an audience without access to the equipment. 
African cultures are essentially oral, wherein information is processed through an 
“interactive social processes” (Claasen-Veldsman and Snyman, 2005):1). Policy 
makers need to pay attention to such social and cultural biases before rolling out 
communication strategies for health policy changes.  
 
 
When communication strategies are employed as part of the policy change process,  
then it should involve evidential approaches (Kreuter and McClure, 2004). Such an 
approach augments the perceived relevance of a health problem to the target group by 
presenting evidence of the impact of the health problem on the targeted population 
(Kreuter and McClure, 2004). Provision of information is a crucial ingredient in any 
policy change (Hausmann-Muela et al., 2003, Lettenmaier, 2003, Mulligan et al., 
2006).  Necessary information needs to be carried through appropriate communication 
strategies in order to change perceptions, attitudes or social norms that might limit the 
impact of new health interventions and policy implementation (Hausmann-Muela et 
al., 2003). Because policies that aim to introduce new drugs into the health system are 
often met with resistance from the community (Hausmann-Muela et al., 2003), there 
is need to give full information and education about the new policy to the 
beneficiaries in order to convince them of its merits (Hausmann-Muela et al., 2003, 
Lettenmaier, 2003, Mulligan et al., 2006). There is no current literature on how 
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Key information on an illness has the potential to change people‟s knowledge and 
behaviour and investment in communication infrastructure can improve people‟s 
health status (Mozumder and Marathe, 2007). The authors add that poor investment in 
IEC infrastructure is thus to blame for the inefficiency in primary health care systems 
in rural areas of developing countries. Poor health education and information are often 
manifested in misconceptions of disease causation and cure (Mwenesi et al., 1995, 
Eriksen et al., 2005). In light of these misconceptions, health information, education 
and communication can be used to transform people‟s ways of thinking and to 
increase their level of knowledge about illnesses and health interventions (Mozumder 
and Marathe, 2007, Emmanuel, undated). Information, Education and Communication 
(IEC) strategies should be tailored to different audiences, based on recognition and 
understanding of differences between target groups in their needs and concerns 
(Kreuter and McClure, 2004).  
 
IEC materials are considered the first step in a communication strategy targeting 
health care beneficiaries. Although many countries across Africa have invested in IEC 
materials during policy changes in malaria drugs, few have endeavoured to evaluate 
the impact of these strategies at the community level. There is also dearth of literature 
on the extent to which communication strategies can influence malaria treatment 
outcomes. Existing literature suggests that well-developed communication strategies 
not only help in increasing awareness of the policy change but also improve 
acceptance and compliance with drug regimens such as ACTs (Lettenmaier, 2003, 
Mozumder and Marathe, 2007). Acceptance and compliance with new drugs form part 
of health education, which is important in disease control. This area has not received 
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community acceptance and involvement in malaria control interventions (Ghosh et al., 
2006).  
 
A number of channels can be used to pass health information, but in many rural 
communities, communication strategies that involve radio and interpersonal 
interactions are the best options to reach this part of the population (Eriksen et al., 
2005, Mozumder and Marathe, 2007). The interpersonal interaction helps community 
members in identifying symptoms and in mobilising resources for treatment 
(Mozumder and Marathe, 2007). Information passed between community members, if 
well communicated and accompanied by collective decision-making, improves 
outcomes of home-based treatment (Mozumder and Marathe, 2007). Oral 
communication is one of the best methods for communicating with people in rural 
areas in the sub-Saharan Africa because of the oral nature of African cultures 
(Claasen-Veldsman and Snyman, 2005). Information orally delivered by health 
experts is more appealing than one that is delivered by any other person because 
expert sources are generally regarded by the community as most credible (Kreuter and 
McClure, 2004). Oral interpersonal communication would be more beneficial to 
women than men because women usually prefer to meet the information providers 
rather than listening to the radio (Emmanuel, undated). The best option to reach all 
audiences is the use of multiple information delivery channels (Eriksen et al., 2005), 
meaning that using one method of information delivery may alienate other groups of 
people.  
 
Above all, the radio remains the cheapest and most widespread source of information 
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medium is taken seriously (Eriksen et al., 2005) and this influences user-perceptions 
and attitudes (Mwisongo, 2007). During the drug policy change from CQ to SP in 
Tanzania, for example, information from the government about the policy change was 
passed to the public at the time when the media was already presenting negative 
information about SP (Eriksen et al., 2005, Mwisongo, 2007). The official 
communication about SP might have added to the confusion because the public was 
already receiving information through radios and newspapers about the possible 
negative effects of SP. Simultaneously, the government used the same media to pass 
information about the benefits of the drug and the need to change from CQ to SP. 
Such contradictory messages about drug policy change may have lead to confusion 
among policy beneficiaries thereby making them form divided opinions about the 
drug policy change (Mwisongo, 2007). The media may therefore, play both positive 
and negative roles during policy change, which in turn, could lead to success or 
failure of a policy.  
 
Communication strategies for drug policy changes often involve training of key 
implementation staff and multi-media communication using a number of languages 
that are relevant to recipients. Mulligan and others give a description of the Tanzania 
communication strategy during the switch from CQ to SP. The communication 
strategy involved training of regional medical representatives who later trained 
District Health Management Teams (DHMTs) (Mulligan et al., 2006). These in turn 
trained at least one health worker from each of the selected districts. Training 
involved primary prescribers: clinicians, pharmacists, clinical officers and nurses. 
Only 23 of the 114 districts got the initial training with centralised funding from the 
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their own decentralised budgets (Mulligan et al., 2006). Whether this difference could 
have compromised quality of training has not been documented. To pass messages to 
the public, Tanzania hired communication experts to design messages that were 
pretested before being aired to the rest of the population (Mulligan et al., 2006). The 
pretesting may have been crucial in gauging potential impact of the IECs before the 
final roll-out. But there are no documentations about the impact of the pre-test or of 
the final roll-out.  
In Sudan, multimedia strategies were employed during the change from SP to ACTs. 
Their manner of passing information to the public was not a one-off event, instead it 
was periodic, with breaks allowing people to digest information already provided 
before more information was given. For example, radio broadcasts consisted of four 
messages per day for two weeks, then a week-long break before resumption of 
broadcasts (Malik et al., 2006).   
The Zambian policy change to ACT was similar to Tanzania‟s in the initial stages but 
the change had the additional goal of strengthening the performance of the key health 
sector support functions such as supply and procurement, drug regulation, 
communication and health management information systems (Steketee et al., 2008). 
All the countries documented here had an incrementalist model of policy change with 
training of key health sector personnel taking place in stages during policy 
implementation. There are also elements of rigour in the policy making process 
especially in the Tanzanian case where debates involving the general public, 
researchers, traders, pharmaceutical industry and health workers began even before a 
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the different approaches (Kenyan, Zambian, Tanzanian and Sudanese) to 




There is little published literature on how the public perceives policy changes on 1
st
 -
line drugs for uncomplicated malaria. There is also little literature about how 
communities respond to new drugs when one drug replaces another in a new policy, 
or about how people‟s attitudes influence acceptability and compliance with new 
drugs. However, it is known that public perceptions do affect treatment-seeking 
behaviour. Some of these perceptions are influenced by cultural interpretations of 
disease. The interpretations determine what kind of treatment is sought whenever a 
household experiences illness. Many households resort to self-treatment where drugs 
are brought from the informal sector. Quite often, drugs bought from the informal 
sector are inappropriately used. Misuse of pharmaceuticals leads to drug resistance, a 
scenario that calls for changes in 1
st
-line treatment for uncomplicated malaria. The 
consequent implementation of the changes needs to consider all key actors. It is 
particularly important to provide full information about the policy change to the 
public in order to forestall rumours and misconceptions that could become barriers to 
drug use.  The provision of information to the public is meant to change negative 
perceptions, attitudes and social norms. It may involve multi-media approaches aimed 
at maximising the reach of information in order to minimise distortions of the policy 
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3. CHAPTER THREE: METHODOLOGY
3.1 Study Site 
3.1.1 Choice of Study Site 
This study was conducted in a newly created administrative area called Kinango 
district that was initially part of the larger Kwale district in the Coast province of 
Kenya. The district was chosen because; firstly, this remote district is typical of many 
rural settings in Kenya, thus it was interesting to investigate the population‟s 
understanding of drug policy changes and how they receive communication about 
these changes from their disadvantaged position. Secondly, the researcher has prior 
experience of working in the district. This made the logistical challenges of the 
research easier to address than would have been possible in another setting. 
3.1.2  Position and population 
Kinango district is located in south-east Kenya on the border with Tanzania. Being a 
new district, it does not have updated demographic data and what is presented here is 
drawn from the larger Kwale district. In terms of physical accessibility, the road 
network is poor and unpaved and often people get cut-off by heavy rains. The largest 
ethnic group in Kinango district is the Duruma, one of the nine sub-tribes of the 
Mijikenda ethnic group. The socio-cultural institutions of the inhabitants of the larger 
Kwale district rotate around an elaborate system of government controlled by elders 
(gerontocracy). The district is also semi-arid and characterised by high poverty levels 
and poor communication networks including telephone coverage. The MOH indicates 
that the coastal region faces high malaria transmission patterns similar in intensity to 
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values of P. falsiparum parasite prevalence of about 40%.  Kinango district also has 
comparably low coverage of insecticide-treated bed-nets (MOH-Kenya, 2009). 
 
3.2 Study Design and Study Population 
 
This was an exploratory qualitative study focused on different categories of the 
population including adult members of the community especially young parents and 
community opinion leaders. Other key respondents were health care providers at 
primary facility level and health care managers based at the local district hospital. The 
choice of a qualitative design was driven by the need to better understand people‟s 
thoughts and perceptions about policy changes on 1
st
-line treatment for uncomplicated 
malaria because little was known about the subject, and such information is, in the 
first instance, better gathered through in-depth qualitative approaches rather than more 
structured survey tools. Qualitative methods are appropriate in situations where one 
needs to first identify the variables that might later, in this case, in another study, be 
tested quantitatively (Hoepfl, 1997).  
 
3.3 Sampling Strategy and Data Collection Methods  
 
The district has four administrative zones called divisions, namely: Kinango, 
Samburu, Ndavaya and Kasemeni divisions. A convenience sample of three divisions 
was selected for the study. The three were chosen on the basis of the following: (i) the 
district is socially and culturally homogenous because it is dominated by one ethnic 
group, one language and the socio-economic status is dominated by widespread 
poverty. (ii) Two divisions that were farthest from the district headquarters were 
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disadvantage in terms of communication and access to care. (iii) One of the two 
divisions closer to the district headquarters was chosen to allow comparison between 
areas that were more remote and those closer to an urban centre. A cluster of two 
villages per division was randomly selected to bring the total to six villages for the 
study. Data were collected up to a point of redundancy. Sample size determination in 
qualitative studies is not fixed so the number of subjects required for the study is 
identified as the study progresses, with new informants being included because new 
information emerges or with no increase in informants because explanations stop 
emerging from the data being collected (Marshall, 1996).  
The initial number of FGDs was meant to be 12 but this was increased to 14 to just to 
confirm that the FGDs had reached a point of data redundancy. There were 29 in-
depth interviews. These methods were used alongside document reviews and 
observations that were documented in the researcher diary. Figure 1 presents the tools 
used in data collection.  





1. Focus group discussions 
[Moderated by Researcher; field-assistant
takes detailed notes 
14 in total; at village level]
1. In-depth interviews: Community key informants (Village level)
[Moderated by Researcher with a field-worker helping in tape-
recording and note-taking= 20 in total]
1. Individual in-depth interviews with primary health facility managers
(Divisional/community level)
[Moderated and tape-recorded by the researcher with assistance of a note-
taker (6 in total)] 
2. Patient narratives: 8 in total 
[Moderated and tape-recorded by the researcher at health facilities]
Researcher diary: Recording of daily observations and conversations. Done at community level throughout data collection process 
Individual in-depth interviews 
with district health managers 
(District Hq) 
[District Hq; 3 in total, i.e. 
DMOH & facilities manager] 
Reviews of national & district documents (District Headquarters); [Malaria/ACT policy documents, meeting minutes, workshop 
reports]. This continued throughout the study 
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Data were collected for two months starting mid-January and ending in mid-March 
2009. A field assistant with prior training in data collection helped in translation, pilot 
testing tools and data collection. The training of the field assistant was done by the 
KEMRI-Wellcome Trust Research Programme. The main language of communication 
was Kiswahili and in a few cases, the local language was used. Both the researcher 
and the field assistant are fluent in English and Kiswahili. The field assistant is also a 
native speaker of the local language. The researcher and field assistant translated 
study tools in three languages: from English to Kiswahili and the local Duruma 
language. Accuracy of the translations were confirmed by the researcher and the field 
assistant and through back-translations, and pilot testing where some questions were 
asked in both Kiswahili and the local (Duruma) language to check their accuracy. 
 
3.4 Justification for Data Collection Methods 
 
3.4.1. Document Reviews (n=6) 
Document reviews were necessary to ensure familiarity with content of policy 
documents and discussions, and to feedback on policy implementation process. Such 
familiarity helps to contrast what is on paper and the specific actions taken, besides 
assisting in polishing interview questions for health managers. The documents were 
selected with the assistance of one of the district health managers. The documents 
included the national health policy document, malaria control policy, the AL training 
manual and minutes of meetings at the district level among the District Health 
Management Team (DHMT) members. After all the relevant documents were 
reviewed, comparisons were made between issues arising from each document 
reviewed, reflecting policy intent, and experience of policy implementation. These, 
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managers as well as facility managers, also formed part of the data that were analysed. 
The reviews provided a background to policy change communication and 
implementation and helped clarify what was envisaged in the policy change and 
actual implementation at the community level. Document reviews were important in 
guiding purposive sampling and also familiarised the researcher with content and 
context of the study (Mack et al., 2005, CDC, 2009). 
3.4.2 Researcher Diary 
Diaries are important in highlighting thoughts and reflections and to “triangulate 
research on information behaviour” (Hyldegard, 2009):7). Diaries improve rigour in 
qualitative research (Clayton and Thorne, 2000). A researcher diary was kept 
throughout the study period. The diary permitted constant reflection on the 
researcher‟s experiences as well as helping in identifying emerging thoughts about 
issues and ideas that were followed up in subsequent interviews. The researcher 
constantly referred to diary notes during data analysis so as to compare what was 
observed with what was said during the process of data collection hence contributing 
to reliability and validity of data. Part of the observations included population groups 
at health facilities, who said what in FGDs and with what intensity, and the social 
circumstances and their relationships with the findings. 
3.5.3 Individual In-depth Interviews (n=29) 
The use of individual in-depth interviews to collect exploratory qualitative data is 
recommended (Lofland and Lofland, 1995, Patton, 2002). This method emphasises 
verbal communication and are efficient in discovering underlying attitudes and 
motivations towards an intervention or situation (Lofland and Lofland, 1995). The 











37 | P a g e  
 
are good in collecting data on sensitive topics, experiences, feelings, knowledge, 
thoughts, expectations and perceived changes, following an intervention (Patton, 
2002, Mack et al., 2005).   
 
Individual in-depth interviews were conducted with three categories of respondents. 
These included three members of the DHMT, six health workers from six primary 
health facilities and 17 community leaders and three mothers just from the dispensary 
(n=29). DHMT top officials were purposively selected given their administrative roles 
that included over-seeing policy implementation day-to-day running of the district 
health services. They provided information on the general malaria situation in the 
district, their role in policy communication and implementation, and influences over 
uptake of drugs.  
 
In-depth interviews with primary health facility managers were required because they 
were in charge of health service provision at the local level and feed back to district 
health managers on all health matters at community level. Besides, they constituted 
the lowest link between the community and the DHMT. A convenient sample of two 
facilities per division was chosen and in-charges were interviewed. This made a total 
of six facilities for the study and six in-charges. The facilities were chosen at the 
divisional level because health facilities are not available in every village. All 
interviews with health managers/workers were conducted in their respective offices. 
 
The researcher took brief notes while the field-worker was required to take detailed 
notes as well as operate the recorder. The primary facility health workers provided 
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implementation, policy communication strategies, barriers and facilitators to policy 
changes/implementation at the local level, perceived community response to policy 
changes, attitudes to recommended drug and general uptake of malaria drugs. 
 
A total of 20 key informants at the community level were also purposively selected 
from among the six sampled villages. These participants were chosen based on their 
presumed knowledge of local culture, administrative issues, and health and malaria 
treatment. In this regard, they were most likely to have been actively involved in, or 
experienced first-hand, key events such as policy change communication. Those 
interviewed included the following: 17 community leaders including four local chiefs, 
eight village level leaders and five women group leaders. There were also three 
mothers (n=20). As custodians of community culture and leadership, the views of 
these leaders were necessary as culture plays a role in the community interpretation of 
disease and treatment seeking.  Besides, they were likely to have had experience with 
the earlier 1
st
-line drug, CQ. The mothers were selected because they had just taken 
their children to the formal health sector and had first-hand information about malaria 
treatment.  
 
The researcher acted as interviewer in the key informant interviews while the field 
assistant managed the recorder. The field assistant also took detailed notes during the 
interviews. The participants provided information on their experience with malaria, 
types of health provision available in the community, their views on available malaria 
drugs. Other areas of questioning included their responses to recent malaria drug 
changes and why such responses; whether the community got any communication 
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and from whom/what sources; usefulness of the communication, and what reactions to 
it.  Each interview session lasted about 45 minutes. All community key informant 
interviews were conducted at the respective homes while the chiefs were interviewed 
at their offices. 
 
3.4.4 Patient Narratives (n=8) 
Narratives reveal qualities of individual or group experiences in a way that other 
forms of research cannot (Connelly and Clandinin, 1990). Narratives also provide 
descriptive knowledge that is understood in context (Richmond, 2002). Narratives 
seek to collect data to describe lives, and are a method to find the voice of the 
participant in a particular time, place or setting (Richmond, 2002). This was important 
for the study as it also sought to understand individual experiences with drug policy 
changes in given contexts.  
 
Patients for the narratives were chosen purposively from the nearest three of the six 
health facilities that were visited. The argument behind the choice was that the study 
area is culturally and socially homogeneous and so did not require a large number of 
narratives from many health facilities. Two narratives were conducted from the first 
facility, four from the second and two narratives from the last facility. Patients were 
first asked to narrate the story of their illnesses and use of the formal health care and 
thereafter probed on their choice of drugs, their perceptions on available drugs and 
how they received communication about health services in general and malaria drugs 
in particular. The narratives elicited real life experiences when seeking treatment, 
experiences with various drugs, the shocks of policy change and communication 
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analysis, but only one edited version was illustrated here, partly to act as an example 
and partly to minimize the size of the thesis.  
 
3.4.5 Informal Conversational Interviews (n=11) 
Informal conversation with participants has advantages in that the participants are in 
their natural settings and are not subjected to paper-work and consent procedures. 
Informal conversational interview are advantageous because the interviews are highly 
individualised and relevant to the individual (Patton, 2002). Thus, they are likely to 
produce information or insights that the interviewer could not have anticipated.  
 
Informal conversational interviews were done conveniently with individuals or groups 
like youths at social places and around schools and markets, at chiefs‟ meetings, a 
funeral and relief food distribution points. These spontaneous conversations continued 
throughout the study and were conducted by the researcher with ordinary adult men 
and women, both young and elderly. There was no tape-recording or note-taking 
during the informal interviews, instead the researcher after the conversations, 
immediately noted down outcomes to ensure no important data were lost. The 
interviews provided additional information on experiences with various malaria drugs, 
perceptions on policy changes on 1
st
-line treatment for uncomplicated malaria and 
sources of information on government and facility matters. These were conducted 
spontaneously until there was data saturation.  Six informal conversational interviews 
were conducted with individuals and five with groups.  
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Focus group discussions are appropriate in qualitative studies because they encourage 
verbal communication and are efficient in discovering underlying attitudes and 
motivations towards an intervention or situation data is recommended (Lofland and 
Lofland, 1995, Patton, 2002). FGDs were the last to be conducted at each village 
because they acted as debating arena for issues emerging from the interviews as well 
as being an avenue for debates on issues relevant to the study. FGDs normally ensure 
free flow of information and allow agreements and disagreements (Mack et al., 2005).  
The FGD participants were selected purposively with the help of community leaders. 
Among male participants, most were household heads with at least a child aged 10 
years and below and must have lived in the village in the past one year. Female 
participants came from similarly young households. Young households were chosen 
because they are likely to have had experiences with the latest policy changes on 
malaria drugs because of their young children who are vulnerable to malaria infection. 
Male and female participants were interviewed separately. Each FGD included a 
minimum of ten and a maximum of 12 ordinary community members. Topics 
discussed included the following: views on recent malaria drug policy changes; what 
responses to the changes and why; communication about recent drug policy changes; 
what sort of communication, who got the communication, from what sources; 
usefulness of the communication, and what reactions to the communication. Also 
explored were what influences choice of health care and views over new drugs. 
When residents of socially and culturally homogeneous areas are interviewed about 
their attitudes, experiences and beliefs, there is usually a large measure of agreements 
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important when the respondents are information rich (Patton, 2002). Consequently, a 
large sample of participants was not necessary for the study so as to secure high 
reliability and validity in data. A maximum of two FGDs per village- one with men 
and one with women- were conducted. Two more FGDs- one each with men and 
women- were conducted to ascertain data saturation. All FGDs were tape-recorded. 
The researcher moderated the discussions while a field-worker took detailed notes. 
FGDs were conducted at communally agreed central points including schools, 
churches and chiefs‟ compounds. 
 
3.5 Data management 
 
All interviews and discussions were tape-recorded except for informal conversations. 
Field notes from observations and informal interviews were kept in an envelope and 
locked in a drawer. Tape recorded interviews were downloaded into a password-
secured computer in the custody of the researcher.  
  
3.6 Ethical issues 
 
Ethical approval was obtained from the University of Cape Town Ethical Review 
committee and the Kenya Medical Research Institute (KEMRI) Ethical Review 
Board. The purpose and methods of the study were explained to all study participants 
in line with ethical requirements. Informed written consent was obtained before the 
interviews or discussions begun and participants were given copies of information 
sheets about the study to retain for future reference. All participants studied were 
competent adults in their ability to make informed consent. Consent forms, question 
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was given to local health care managers, local authorities including village elders and 
chiefs of respective locations who acted as points of entry into the community. All 
participants were assured of confidentiality. It was also explained to the participants 
that the benefits of this study could not be immediate and if any would be communal 
rather than individual. The study involved no invasive procedures and caused no pain 
to participants. The only drawback was that participants might have felt 
inconvenienced with time and questions that they might have regarded as personal. 
Results of the study would be communicated soon after the study is examined and 
approved. The dissemination plan included the proposal of a journal paper for a wider 
literate audience and policy makers and through brief notes containing key findings 
for the district health workers and managers. Public meetings were proposed for the 
rest of the community to give feedback on the findings. 
 
3.7 Data processing and analysis 
 
All interviews were audio-recorded, transcribed and then translated into English. 
Transcriptions were made by the researcher and field assistant. Any discrepancies 
from the transcriptions were resolved by re-listening to the recordings. Interviews 
with the district health managers and health workers were conducted in English. All 
transcriptions were processed electronically. Coding and analysis were performed 
manually by the researcher by developing a matrix for emerging categories and 
themes. The themes and categories centred on phrases, incidents and behaviour during 
interviews, discussions, and observations. Unusual statements were also considered as 
a basis for analytical categories. Data from each theme or category were identified 
and analysed using constant comparison (Thorne, 2000).  Each item was compared 
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informant interviews with health personnel at district and divisional levels, and 
community members were separately compared and contrasted with each other to 
identify patterns, consensus, differences, variations or contradictions and weighing the 
relative importance of information. Comparisons and contrasting were also made 
between female and male respondents, within groups and between villages. Concepts 
and themes thus identified were compared with those from FGDs. Field notes and 
review notes were explored for content and contrasted with themes and concepts from 
FGDs and key informant interviews. Analysis of narrative focused on how ideas and 
behaviours were sequenced, the perceptive differences in the narratives and how these 
have worked to influence receptivity to policy changes in malaria drugs.  
 
The analytical categories were then explained and interpreted in line with the research 
objectives and the themes developed from the data (Malterud, 2001). Preliminary 
analysis was presented before the Social and Behavioral Research team at KEMRI-
Wellcome Trust Research Programme. Feedback from the team was incorporated in 
the final analysis.  The data were also subjected to iterative methods where sets of 
concepts from various data sources were examined, constructs developed and 
compared with each other. The researcher noted his role in producing certain classes 
of knowledge, how and why certain conclusions were arrived at, and how the results 
function to shape community responses to changes in 1
st
 line treatment for malaria.  
 
3.8 Validity and Reliability 
 
To ensure rigour in the research process, the following precautions were taken as 
suggested by (Olshansky, 2006, Golafshani, 2003), regarding validity and reliability 
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i) Constant reviews of question guides in line with research objectives,  
ii) Comprehensive recording of data using audio-tapes and detailed transcription 
involving two individuals. The transcriptions were compared for consistency 
and any discrepancies were resolved by listening to the recordings together.  
iii) Triangulation involved three approaches: across data sources (district health 
managers, primary health facility staff, community key informants including cultural 
leaders, leaders of local authorities, women group leaders, and ordinary members 
considered to have better information about malaria drug policy changes; ordinary 
adults including parents of young children, youths and the elderly); across data 
collection methods (in-depth interviews, FGDs, informal interviews, narratives, 
observations and document reviews) and across analytical methods (constant 
comparisons, reflexive analysis, iterative methods and peer reviews). Familiarity of 
the researcher with the study population made participants feel at ease and this most 
likely increased level of trust between the researcher and participants. Mutual trust 
was important for successful recruitment and the quality and flow of information from 
the participants. The researcher also became very familiar with the context that was 
built into the analysis and interpretation of the findings. 
 
3.9 Limitations of the Study 
 
The study was only in only one district. While rural communities are similar in many 
ways, cultural differences between settings may limit the application of the findings 
culturally and socially different settings. Limitation in scope was also registered in the 
fact that the study is purely qualitative and so misses the strength that would have 
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4. CHAPTER FOUR: FINDINGS
4.1 Introduction 
The data presented here are drawn from document reviews, views and experiences of 
ordinary members of the community, primary health facilities, heath managers and 
diary records. The first part of this chapter provides an overview of the policy change 
strategy including the context and processes of the change. The second part presents 
findings on the overall outcomes of the policy change in the study district. The third 
section presents factors that explain these outcomes. 
4.2 Overview of the policy change from SP to AL 
The date of the official policy change to AL was 2004 although the drug only reached 
health facilities in the study district 32 months later in 2006. This was according to a 
member of the DHMT. Apparently, the delay affected the whole country and this was 
confirmed from secondary data sources (Amin et al., 2007). It was due to the 
following reasons: concerns over sustainable financing for AL, competing national 
and international interests, procurement regulations and lack of timely funding from 
the Global Fund to fight HIV/AIDS, Tuberculosis and Malaria (DHMT minutes 1 & 
2, (Kangwana et al., 2009). The arrival of AL also did not displace earlier 
antimalarials, CQ and SP. A spot-check by the researcher confirmed the presence of 
these drugs in most health facilities in the district and in most of the local shops. SP is 
recommended as 1
st-
line treatment for pregnant women, a factor that ensures its











47 | P a g e  
 
As early as 2001, various studies in Kenya had indicated that the SP treatment failure 
rate was over 25%, a threshold used as the bench-mark in determining drug policy 
change in Kenya (MOH-Kenya, 2006). Treatment failure is defined as the “failure of 
a drug to achieve the desired therapeutic response after the initiation of therapy” 
(MOH-Kenya, 2006):4). It can result from many sources including: poor adherence to 
treatment, unusual pharmacokinetic properties in an individual, drug resistance or 
wrong diagnosis hence wrong treatment (MOH-Kenya, 2006). At the end of 2003, the 
Kenyan Drug Policy Technical Working Group held its first meeting to review data 
on SP and AQ sensitivity and think about alternative 1
st
-line treatment for 
uncomplicated malaria (MOH-Kenya, 2006). Among the alternatives considered were 
AL and AQ-AS (AS= artesunate) in line with the WHO demands for countries to 
avoid using monotherapies in order to preserve the life of artemisinins (Amin et al., 
2007). The choice between the two was complicated due to the lack of efficacy 
studies and unclarity about who to undertake and who to fund such studies (Amin et 
al., 2007). In 2004, at the intervention of the WHO, regional and international 
evidence on efficacy was used to push for the policy change. 
 
Apart from widespread resistance to SP, the decision to select AL was because it was 
the only co-formulated ACT that had passed rigorous international regulatory scrutiny 
(WHO, 2008).Therefore, AL was the only ACT purchasable by countries that needed 
to change 1
st
-line treatment policy to an ACT.  Drugs can be administered with 
artemisinins, for example, AQ + AS but for ease of use for outpatients, an ACT 
regimen needs to be co-formulated, that is, the  various drugs must all be formulated 
in the same tablet (Laxminarayan and Gelband, 2009). The official announcement 
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HIV/Aids, TB and Malaria (GFATM) enabled initial roll out of AL in two phases. 
The first phase (2006/2007) involved free distribution of AL to the public sector 
facilities including: government, mission and NGO health facilities. The 2008/2009 
phase involved, first the formal private sector followed by retail non-formal sector, 
but there was still no AL in the informal sector at the close of 2009. The phased roll 
out was an attempt to win public trust over the safety of the new drug (Amin et al., 
2007).  Figure 2 presents a graphical representation of the policy change process. 
 







     Debates over AL as replacement 
     for SP, with the following factors delaying roll-out  
     of AL: 
     -Concerns over sustainable financing 
     -Competing interests (opposition) 
     -Review of treatment guidelines 
     -Procurement regulations (red tape) 
     -Lack of timely funding from GFATM 
            Debates 
CQ   
  SP    SP      SP 
           AL 






At the time of the official announcement of AL as the replacement for SP, a 
conference was held in Nairobi for 13 Francophone countries that had adopted AQ-
AS as first line drug for uncomplicated malaria (Amin et al., 2007). The conference, 
on its conclusion, sent conflicting messages to the Kenyan public because its 
resolutions appeared to endorse AQ-AS as the recommended 1
st
-line treatment for 
uncomplicated malaria (Amin et al., 2007). It was unclear why a Francophone 
   1998 2001/02        2003 2004 2005 2006/07      2008/09 
AL is officially 
announced to 
replace SP 
SP replaces AQ as first-
line treatment for malaria 
1. Development of IEC strategies 
2. Training of health staff 
3. First phase of AL roll-out 
(Public sector: government, NGO 
& mission health facilities) 
Second phase of AL roll-out 
(Private sector: formal first, 
then informal retail outlets 
later) 
 
Efficacy studies show 
evidence of resistance to SP 
First meeting of the Kenya Drug 
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conference was held in Kenya, an Anglophone, if not for external forces opposed to 
adoption of AL at the expense of AQ-AS. Adding to the confusion, the 
Pharmaceutical Society of Kenya (PSK), representing a national grouping of 
pharmacists and mostly private pharmaceutical firms, opposed the move to AL and 
questioned the legitimacy of the switch from SP (Amin et al., 2007). Their opposition 
to the change to AL was not based on any scientific evidence but on the grounds of 
transparency in the choice of AL. 
 
The PSK draws some of its membership from the health personnel and its influence 
may partly explain why some district health managers and primary facility providers 
still expressed mild opposition to AL at the time of the study. One of the managers 
said: “We keep asking why AL and not any other ACT? This question has not been 
answered and sometimes you come to believe that the change to AL was facilitated by 
some reasons other than health concerns ... may be someone just wanted to make 
money.”  Two DHMT members and three primary health workers questioned why AL 
was selected when it was obvious that it had a more difficult regimen compared to 
other alternatives. But in opposition to this view, documents used during training, 
which the researcher reviewed at the district hospital, clarified that at the time AL was 
being considered to replace SP, it was the only co-formulated ACT and therefore had 
no other competing ACT. It could have been this consideration that was not 
communicated to some health workers/managers in the district.   
 
The sub-committees enlisted by the Department of Malaria Control (DOMC) to 
recommend best methods to implement the AL policy took 23 months to review 











50 | P a g e  
 
only available in the first quarter of 2006 (MOH-Kenya, 2006). Approximately 8500 
copies of the guidelines were distributed to health workers across the country through 
the DHMT and during in-service training for health workers and health managers 
(MOH-Kenya, 2006). These copies were too few considering that the training also 
involved the private sector. 
 
The new treatment guidelines emphasised careful assessment of fever and use of AL. 
It targeted health staff in Kenya‟s general and specialist hospitals and health centres, 
and meant for both pre-service and in-service training of doctors, clinical officers, 
nurses, pharmacists and pharmacy technicians, and laboratory workers involved in 
diagnosing and managing malaria (MOH-Kenya, 2006). The emphasis on assessing 
cause of fever before treating with AL was meant to reduce the chances of resistance 
by reserving AL for patients who are truly malaria positive, wise use of limited 
resources, and to treat patients for the disease they had (MOH-Kenya, 2006). The new 
guidelines proposed parasitological diagnosis for all adults and children above the age 
of five and presumptive treatment for children under-five years of age in areas with 
high transmission rates. Use of Rapid Diagnostic Tests (RDT) was recommended for 
all age groups in low risk areas. However, across the country only 34% of health 
centres in the periphery have microscopy and less than 7% have RDTs (MOH-Kenya, 
2009). There were no RDTs in all the primary health facilities visited during the 
study.  
 
Compared to CQ or SP, AL involves a more complex dosage. An adult dose for CQ 
had 10 tablets taken within three days. The first dose involved four tablets followed 
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consisting of two tablets each were taken on the second and third days respectively (4 
– 2 – 2 – 2 pattern). An adult SP dose only involved three tablets taken at one time. 
AL has a three-day dose regime for all patients and with a larger number of tablets. 
Those aged 14 years plus and weighing 34kg and above, have a dosing pattern 
involving four tablets after every eight to 12 hours for three days, giving a total of 24 
tablets. Table 1 represents the recommended AL dose schedule for all ages: 
 
Table 1: Dosing schedule for artemether-lumefantrine (AL) 
No. of tablets recommended at approximate timing (hours) of dosing (each tablet contains 20mg A and 
120mg L) 
 
Body weight  0hr  8hrs 24hrs 36hrs 48hrs 60hrs  
5–14kg (<3y)    1   1   1   1   1   1 
15–24kg (4–8 y)    2   2   2   2   2   2 
25–34kg (9–14 y)   3   3   3   3   3  3 
>34 kg (>14 y)    4   4   4   4   4   4  
 
The regimen may be simplified as follows: The second dose on the first day should be given anytime 
between 8 and 12 h after the first dose. Dosage on the second and third days is twice a day (morning 
and evening). 
 
(Source: MOH, 2006) 
 
The training manual indicated that training for policy implementation was undertaken 
through a three-tier system cascading down from the national level to the provinces 
and districts. It involved 405 Training of Trainers (TOTs) nationwide (Figure 3). Two 
national level trainings were conducted for provincial medical officers (PMOs), 
representatives from major private hospitals, representatives from NGOs and religious 
groups as well as professional bodies (Amin et al., 2007). Provincial training in June 
2006 involved members of the DHMTs and senior district health staff. District 
training took place two months later and included primary health facility staff (nurses, 
public health officers, clinical officers, lab technicians and pharmacists). The minutes 
of DHMT meetings, available at the study district, stated that the training for health 
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course and was facilitated by the DHMT. The training did not include clinical 
practice- guidelines developed to help health care professionals and patients make 
decisions about screening, prevention, or treatment of a specific health condition.  The 
training targeted 60% of key health workers and was meant to be completed before 
roll-out of AL (Amin et al., 2007). It is not clear how or whether the 60% target was 
accomplished. Interviews with the DHMT revealed that delays in disbursement of 
funds from GFATM meant that AL was distributed before some health personnel 
were trained. Altogether, about 9000 health workers from government, mission and 
NGO health facilities were targeted for training countrywide, but this objective was 
most likely not achieved due to delays in disbursement of funds from donors (MOH-
Kenya, 2006). It was not immediately clear how many health workers were actually 
trained. 
The training manuals were silent over what was expected of the health 
workers/managers in terms of directly linking with the larger community in order to 
pass relevant information about the policy change. As stated by a member of the 
DHMT: “…nothing happened from the district headquarters to educate the 
community about the switch from SP to AL, specifically because there were no 
resources allocated for the same purpose….”  The training itself, had conflicting 
messages: first, health workers were required to confirm parasitic diagnosis before 
prescribing AL even though many primary facilities did not receive any diagnostic 
test kits. With this contradiction, some of the health workers interviewed reported that 
they did not know what to do with AL. This influenced some of them to continue 
administering SP and AQ. All DHMT members confirmed in separate interviews that 
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minutes indicated that some health workers were confused whether or not AQ was 
still in use.  
 
The IEC materials employed to effect the change from SP to AL involved multi-
media approaches using various languages: English, Kiswahili and vernacular 
languages. The strategy included 10 spots for the print-media, 481 television spots, 
3064 for vernacular radio stations, community road shows, 0.1million posters and 
0.5million brochures. The campaign lasted three months ending in the last quarter of 
2006 and targeted 60% of primary care-givers (Amin et al., 2007). Most of the 
primary caregivers are usually women. The IEC materials were developed in April 
2006 but it was not clear when they were implemented though the implementation 
ended in last quarter of 2006. 
 
4.3 Overall outcome of the policy communication strategy 
 
 
4.3.1 Knowledge of the policy change 
 
The interviews and discussions at the community level revealed that although there 
was a general awareness of AL as drug found at public health facilities, there was 
minimal knowledge about it as the officially recommended 1
st
-line treatment for 
uncomplicated malaria. In all the FGDs and informal interviews conducted at the 
village level, only two women knew AL by name and recognised it as the current 1
st
-
line treatment for uncomplicated malaria. One of the women was a leader of a trading 
group and the other was a leader in a local community-based organisation. The same 
women were the only ones who had accurate knowledge about why malaria drug 
policies change. Asked how they got health information, they mentioned that they had 
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better education than theirs and had access to information by virtue of their residence 
close to a semi-urban centre. One of them said: “By virtue of literacy, I can listen to 
the radio or read posters and know exactly what is going on in the health front. We 
also read newspapers.” 
 
Among the key informants, only four women and two men had accurate information 
about drug changes and AL, symbolising the minimal impact of the policy change 
communication strategy. A statement from a narrative given by a female patient best 
exemplifies the failure in policy communication:  “I have no information concerning 
any new drugs for malaria and I am not aware of any changes in drugs but if indeed 
there are changes in drugs then the new drugs are not yet around here.” This patient 
had AL tablets issued by the dispensary and she did not know what drugs they were or 
what they treated. On how the drugs had changed, the responses were varied in all the 
interviews and FGDs. Some participants mentioned that drugs have changed from CQ 
to AQ while others believed that drugs changed from CQ to SP or some popular 
painkillers like maramoja and panadol. The actual changes in 1
st
-line treatment for 
uncomplicated malaria occurred from CQ to SP to AL.  
 
Finally, a few respondents suggested that the policy changes were specific to health 
needs of particular groups. In one FGD, individuals supportive of this view felt that 
the changes in drug policies did not affect the whole country or everyone in a locality 
since only those who could not find appropriate drugs from the shops were affected 
by subsequent drug changes. A female participant said: “It [policy change] is not for 
everyone. People who cannot be cured by the drugs we know are the ones affected by 
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cannot cure us anymore.” A similar view was also expressed by three key informant 
interviews in two neighbouring villages as well as in one FGD with men.  
 
4.3.2 Perceptions about why drug change  
 
There were varied views from the study participants on why malaria drugs often 
change. The most widely shared view coming from virtually every interview and 
discussion across the district including health workers and managers was that the 
policy changes are motivated by profit.  Although misplaced, participants from all the 
villages pointed out that the government allows one company after another to make 
money through the change of policies. A middle-aged man in one FGD gave the 
following response: “I think CQ is no longer available because the company 
associated with it had made a lot of money so the government thought it was time to 
give another company chance to make money. That explains why we have a different 
kind of drugs for malaria.” This view was apparent in all FGDs for both women and 
men as well as in 17 out of 20 key informant interviews in the villages. Two out of the 
three DHMT members, and four out of six primary health facility workers also shared 
a similar view. Apart from health workers and managers, most study participants also 
singled out supportive treatment with antipyretics as serving no purpose other than 
enhancing profitability of companies supplying the drugs. One of the mothers had this 
to say: “We only take what we feel is right with the illness, not all the other drugs that 
we are given so that someone somewhere can make money.”  
 
Eight FGDs and seven informal interviews also revealed that participants believed 
that the policy changes were necessitated by the desire of the government to test the 
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remote villages, and much less strongly among key informants at the community level 
and in less remote villages. This may indicate some social differentiation between key 
informants and peri-urban dwellers on the one hand, and more remote inhabitants.  
Discussions about policy changes being driven by profit motives also included the 
concern that facilities charged fees for malaria treatment rather than providing it free 
of charge. Study participants viewed the contradiction between the government policy 
on free malaria treatment and the informal or under-the-counter charges as an attempt 
by the government to sell its own drugs. A community leader commented thus: 
“When a government advertises its own drugs to poor people like us and says they 
are free when they are not, it shows you that there is something wrong with it. Can 
anything good come from such a government?”  This was a view expressed especially 
in more remote villages, which included the majority of participants in11 FGDs and a 
few in-depth interviews and one informal interview.  
 
Asked about whose responsibility it was to change drug policies, all in-depth 
interviews and the majority of the participants in all FGD and informal interviews 
acknowledged that the government is responsible for changing policies on malaria 
drugs. At the same time, most FGD participants were of the view that the policy 
changes have not contributed to better treatment for malaria. In 12 FGDs and nine 
informal interviews, therefore, most participants saw the policy changes as an 
indication of bad practice by the government. One female participant reasoned thus: 
“The change of drugs is very bad because when we are already used to one type of 
drug then one day we are given a new one whose name we do not know. This makes 
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Finally, very few middle-aged men in one FGD thought that drugs alternate across 
seasons. They stated that they were waiting for the return of the CQ season: “We do 
not know that drugs have changed, but we know there are seasons for malaria drugs 
and it is now the season for malara-tab (AQ) and others. When the CQ season 
returns, we will have no problems over which drug to use in malaria treatment.” 
 
4.3.3 Perceptions about AL vis-à-vis other drugs 
 
Community respondents‟ views about AL in comparison to other antimalarials 
revolved around two sets of issues: the safety of AL and its effectiveness.  Concerns 
about AL‟s safety were identified from 14 in-depth interviews in four villages, nine 
FGDs and seven informal interviews. More men than women maintained that AL was 
harmful. Older individuals in their 50s and 60s were also concerned about the dangers 
posed by the change of drugs to AL. To emphasise their point, a male key informant 
said:“.... When taking the new drugs, we ask ourselves many questions: „where are 
they from and why cannot we be given the ones that we know? What harm can they 
cause to us?‟ This makes us afraid….. We use the drugs but inwardly we ask 
ourselves why they are different drugs from the ones we used before and whether they 
are good at treating malaria…” There were no differences in opinion between 
villages in the peri-urban and more remote areas about AL as a harmful drug. Others 
saw AL as harmful because it was not recommended for expectant women [malaria 
treatment guidelines in Kenya require treatment of expectant women with SP (MOH-
Kenya, 2006)]. A young male participant said: “Recently, I asked my wife why she 
was given fewer drugs than those given to everyone who goes to the dispensary and 
she told me that the other drug [AL] cannot be given to pregnant women. That 
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In terms of the effectiveness of AL, only 6 out of the 20 key informant interviews at 
the community level thought that AL was better than its predecessor, SP. Some 
viewed AL as a strong drug that was effective in treating strong malaria. A young 
woman in an FGD said: “We visit dispensaries when we have strong malaria that 
cannot be treated with drugs from the shops.” Those who held that AL was weak 
considered it as effective only in treating weak malaria. Strong malaria, according to 
the respondents, presents with vomiting, shivering and loss of appetite, and the patient 
cannot work at all. Weak malaria on the other hand, presents mild headache, weak 
joints but the patient is able to go about their businesses.  
Three more specific issues were raised by the community in the discussion of AL‟s 
effectiveness: the number of tablets, recommendations for its use, and the fact that it 
was only one type of antimalarial issued at the dispensary.  
First, the fact that an AL dosage involves many tablets (24 for adults) was interpreted 
by some community members as a sign of its weakness. This was captured in the 
following statement from an FGD with a group of women: “We heard that the 
malaria drugs that we keep using are not good any more... but the new one is not 
good either, because there are 24 tablets to complete a dose instead of just a few. Why 
are the tablets so many if it is a good drug?” In another FGD, a question was posed to 
men regarding whether SP, which had only three tablets, was better than CQ with ten 
tablets. One of the responses, which captured the mood in the discussion, was as 
follows: “For us CQ was the best drug for malaria and we are yet to be told why it is 
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Second, two sets of recommendations were misunderstood by the community and so 
could have affected utilization of AL. Although made for sound scientific reasons, the 
recommendation that patients should take the initial dose of AL at the health facilities 
under the supervision of health workers and that the drug should be taken with (fatty 
food) was not clearly communicated to patients. As such, AL was often considered as 
less useful than CO by members of the community. A key informant gave the 
following statement: “If this new drug is good then why are we being forced to take it 
at the dispensary? Why should a drug be imposed on us if we do not want it? Why 
can‟t we be given the ones that we want… (CQ)?” In two FGDs, a minority of both 
male and female participants observed that AL can only alleviate symptoms of 
malaria or temporarily cure the disease. One male participant in an FGD said: “If 
malaria infection occurs two months after taking these many drugs, I cannot go back 
to the dispensary to be given the same drugs… instead I use herbs as an alternative.”  
A female FGD participant, in support of this view, said the following: “….at one time 
I suffered from malaria and got many drugs from the dispensary. Before one month 
had passed I had a similar problem and when I went back to the dispensary I was 
given the same drugs…the very drugs that failed to treat me….” In summary, one 
young woman said of what some of them do with AL tablets: “…we simply take them 
[drugs] home and keep them… then we try another dispensary… and if it is the same 
drugs, some of us go to the private clinic for injections....”  The requirement that AL 
should be taken with food also had cost implications for households. For poor 
households, this could mean delay in commencing treatment even when drugs are 
already available. A woman in an informal interview said: “Only last week my son 
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because he was told by the health worker not to, unless he has eaten. It forced me to 
ask my neighbour for some mangoes so that he could start taking drugs.”  
 
Third, some study participants were concerned that AL was ineffective because it was 
the only antimalarial consistently issued at the dispensary to malaria patients when 
there were different types of malaria that required different types of drugs. A female 
FGD participant said: “…one type of drug cannot be used to treat everyone because 
people could be suffering from different types of malaria. I suggest that each type of 
malaria should have its own drug….” According to most respondents, the shops 
therefore, offered a better alternative than the dispensary because of the repertoire of 
malaria drugs available. A man participating in an informal interview said: “…the 
shops are better because there are a variety of drugs for different types of malaria.” 
Not everyone agreed that drugs from the shops are better than the dispensary‟s; 
instead the drugs were recognised as ineffective by some participants. A female key 
informant stated: “At the shops one can spend all the money one has on drugs that do 
not work. It is drugs like…. which should be replaced because they do not work.”  
 
4.4 Factors influencing community perceptions about the policy 
changes 
 
4.4.1 Choice of communication channels and failure to involve some key actors 
Apart from the IEC strategy involving print and electronic media, no other means of 
communication was used by the health ministry to pass information about the policy 
change to the population. There was also no assessment to ascertain the effectiveness 
of the IEC strategies. In essence, the communication approach used by the ministry 
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various media, especially the radio for those in rural areas. There was generally a 
weak link between the policy implementers and the beneficiaries because, according 
to the district health managers, the public health officers and local authorities were not 
involved in the policy communication (Figure 3).  
 
Figure 3: AL policy communication from the national headquarters to the community 
 
 
The reliance on the media alone to pass health information was not enough because 
the channels used were not entirely accessible to many in the community. From the 
in-depth interviews and FGDs, the main sources of health information for the 
community at the time of the study included radio, health workers and socio-
economic networks like farming groups. Others were shopkeepers and posters (Figure 
4). The preferred sources of health information that were mentioned randomly in 
FGDs and in-depth interviews included public health officers (PHOs), local 
authorities, teachers and the radio (Figure 5).  
 
All study participants at the community level were asked to specify who, between 
men and women, were likely to have better access to each of the information sources 
                                                                                                      (Missing actors: PHOs & local authorities) 
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identified.  There were general agreements in the following: men would benefit more 
from information passed through radios, posters outside health facility settings, and 
shopkeepers. Said one male participant: “Most of our women here cannot read or 
write and the best way to give them health information is through our local leaders.” 
As a result of illiteracy, also confirmed by a health worker, health information posted 
on health facilities made no sense for many women as stated by one of the female 
participants: “...all we see are graphics and pictures and sometimes we think they are 
decoration in the dispensary.”  Women were mentioned by study participants to have 
better access to health information if such information is passed through local socio-
economic groups and health workers. To confirm this point, one woman in an FGD 
said: “We have no radios and quite often our only sources of information are either 
the health workers or colleagues in women groups.” The radio was seen as unsuitable 
for women who were the primary target audience for the policy change. Most women 
listened to radios at the convenience of their husbands. This was reflected in the 
following quote from a male FGD participant: “When I am away, I keep the radio off 
to preserve batteries ... and I alone can switch it on....” 
In all FGDs and interviews, there was emphasis on interpersonal communication, and 
this was expressed in the following statement by one young male participant said: 
“We are yet to see someone coming to us to tell us that „the name of the best malaria 
drug is (this), and here it is‟. Until that happens, we will continue suffering from 
malaria.” A key informant added the following statement: “…if we have the 
assurance from an „expert‟ that the dispensary drug [AL] is the best in curing 
malaria then we would not mind about the number of tablets.” The PHOs were 
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community. The success of PHOs and local leaders in passing health information was 
reflected in HIV/AIDS campaigns that were largely driven by three actors: public 
health officers, local authorities and head teachers. The results were impressive as 
reported in the FGDs. Study participants expressed good knowledge on the causes of 
HIV/AIDS, transmission mechanisms and prevention methods. They also understood 
the need for an early diagnosis and knew where to get help in case one turned out 
positive. These actors who lead in HIV/AIDS campaigns were never involved in the 
malaria policy communication.  
 
The shopkeeper, as a source of health information, was said by study participants to 
favour men. Men tended to seek treatment from the informal sector while women 
seemed to prefer the formal sector. In all the health facilities visited, there was a much 
larger presence of women than men. In one of the facilities there was only one adult 
man and several women. Focus group discussions showed that men often use informal 
sector drugs and herbs. Female participants added another dimension to the 
discussions: that men controlled most resources in the household and often decided 
what type of treatment is sought and where. A young woman said: “Sometimes I may 
fall sick and I feel that the right place to seek treatment is the dispensary but since I 
am not the one with money, I have to buy local drugs as my husband demands.”  
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4.4.2 The role of the DHMT  
 
The district health managers said that their expectation overall, was to ensure the 
success of policy implementation and, more specifically, to train all key primary 
health workers within the district concerning the policy change. The new treatment 
guidelines outlined that all health workers involved in drug dispensing, as well as 
public health officers, were to be trained during the policy shift. However, only in-
charges of primary health facilities in the district were trained. Interviews with in-
charges in six primary health facilities revealed that not all of them were trained. The 
main reason given by the DHMT for scaling down training to include only in-charges 
was that the budget from the line-ministry catered for a three-day training workshop 
for about 30 participants.  Asked why some in-charges remained untrained, the health 
managers explained that a few cases might have been out of station during the 
training. This was confirmed by one of the in-charges who missed the training 




School Heads: Direct & 
indirect audience with large 
sections of the population 
through parents‟ meetings & 
their children 
Public Health Officers: Can 
access remote areas and have one-on-
one audience with the wider 
community 
Local Authorities: Can 
easily mobilise the community 
for a meeting  
Radio: Direct communication with large 
sections of the community. But health 
information through radio can be confusing 
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In trying to perform their roles, the DHMT members cited the challenge of a lack of 
support from the national headquarters to accomplish their objectives. Apart from 
being forced by circumstances to scale down training, there were also no resources 
allocated for the DHMT to organise community outreach programmes to inform the 
public about the policy change to AL, for example. One member made the following 
remark: “The launch of AL was done through the media and many health workers 
also got information about the change from the media...” The health managers 
reckoned that a better response to AL could have been ensured if the public was 
properly mobilised and prepared for the change of drugs. This, they argued, could 
have been achieved through the involvement of public health officers, all key health 
workers at primary health facilities and the local authorities. The involvement of these 
groups was necessary because they were the closest to the community and would have 
easily passed information about the change of drugs.  
 
According to a DHMT member, poor or no training for health workers could explain 
why health workers ignored malaria treatment guidelines. One DHMT member gave 
the example of guidelines for administering a loading dose for quinine. Health 
workers only got the information about the loading dose from the ministry 
headquarters on notice-boards and were not conversant with the instructions. Those 
who were unclear about expectations of the loading dose were told by the health 
ministry headquarters through their superiors to use the methods that they were 
familiar with. As a member of the DHMT put it, “…the casual handling of important 
information could have affected the move from SP to AL in that health workers, who 
were not trained during the switch from SP to AL, continue to do what they think is 
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like SP and AQ that were no longer recommended. [A loading dose, in Wikipedia 
2007 refers to an initial higher dose of a drug that may be given at the beginning of a 
course of treatment before dropping down to a lower maintenance dose].  
 
4.4.3 Health provider roles, behaviour and practices during the policy change  
Primary health workers influenced the outcome of the policy in various ways: they 
were unclear about their roles in the policy change, had poor communication with 
patients and were accused of corruption by the community. They also dispensed 
inappropriate drugs and delegated duties to unqualified support staff.  
 
All six health workers interviewed were unclear about what was expected of them 
during the policy change. Apart from attending the training, the health workers 
believed that they did not have other roles to play in the policy change process.  
Although they were intended to train their junior staff such as nursing assistants, only 
one reported fulfilling this role and the training reportedly lasted just ten minutes. 
Asked if they made an effort to pass messages to their patients about the policy 
change, one gave the following response: “...We do not have enough time to treat and 
engage several patients in lengthy conversations let alone the larger community….”  
Asked if they usually advised their patients on such issues as adherence, one health 
worker had this to say: “My work is about giving treatment not issues of adherence. 
Besides I have never considered it important to engage the community on such issues 
as change of drugs, but now I see the point.” The lack of dialogue between health 
workers and patients was also manifested in the fact that some patients left facilities 
not knowing which of the drugs they had were anti-malarials. A young mother stated: 
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workers are not clear about what each of them treats.” The lack of communication 
was most likely responsible for some patients referring to AL as paracetamols 
(Narrative in Box 1). Asked what they thought of the treatment they had received, one 
patient affirmed that she would not take the tablets, and two others said that they 
would not finish the dose. This explains how lack of dialogue between providers and 
patients could have contributed to poor uptake of AL. 
Box 1: Narrative of Patient A (Female) 
I had a very bad headache so I bought panadol (paracetamols) from the shop. The third day of using these 
drugs saw my headache worsen and I bought more panadol but the headache did not go away. Then I 
decided to go the hospital at Kinango because I realised I was going to use a lot of money without getting 
better. At the hospital, I explained to the health worker my condition then he wrote a note and instructed 
me to take it to the pharmacist. I have no formal education so I could not understand what was on the note. 
When I reached the pharmacist, I was given the same panadol that I had bought from the shops. The only 
difference was that those from the dispensary were packed in fours. Then I remembered what I heard from 
friends that malaria drugs had been changed and there are better drugs at the dispensary. I never asked for 
the better drugs but accepted the panadols all the same. I took four tablets each time and when I finished 
them I was still sick. So I just waited to see what else I could do. After about a week, I had recovered 
though not fully…. But that was only temporary because I am here with the same problem about 3 weeks 
later. If it takes a week before I recover then I know what to do: I will neither buy drugs from the shops nor 
come to the dispensary for treatment because I believe the drugs do not do well with my body…. 
Furthermore, there were indications that some patients who tried to open dialogue 
with health workers were treated rudely. One young woman said: “I wanted to know 
why I was given [malaria] drugs different from the ones I have known all along but 
the nurse asked me whether I had come to the dispensary to be treated or to know 
what drugs I am taking….” There were some efforts to educate patients in two out of 
the six facilities visited, but education days were not regular because, as clarified by a 
health worker, they depended on the number of patients who reported for treatment 
early in the morning. When a large number of patients presented early in the morning, 
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commencing treatment. However, some patients interviewed at the facilities claimed 
that the topics addressed were mostly irrelevant to their health needs because they 
were tailored to suit expectant and nursing mothers. This was confirmed by a health 
worker who explained that: “Most of the topics addressed are mainly preventive and 
more relevant to expectant and nursing mothers than other patients.” But there were 
also other patients who benefitted from the education programmes as stated by one 
young woman: “Sometimes health workers teach us about illness and what drugs are 
available to treat them. We find this very important since the information comes to us 
without us asking for it….” 
 
One of the issues raised with concern by study participants in the villages was that of 
informal and under-the-counter charges in primary health facilities. Interviews with 
community members and patients at health facilities raised issues bordering on 
conflict of interest and corruption. Some health workers were alleged to engage in 
private business within public health facilities. A young man said: “Yes, the health 
worker will show you two types of drugs…. He would say, „These drugs belong to the 
government, and these other ones are mine. Mine are the best because they are 
stronger; so you choose which ones you want.‟ His drugs are better but more 
expensive….”  A young woman in one of the FGDs added that: “The health worker 
makes a lot of money during weekends because he refers all sick people to visit him at 
his house for treatment and he charges a lot of money.” The rest of the FGD 
supported her statement. Interviewees and FGD participants in four of the six villages 
also claimed that patients who lacked money to pay for the informal charges were 
given incomplete doses. This was done to ensure that the patient did not default 
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but this did not always happen. To emphasise this point, one male FGD participant 
remarked: “If the health worker gives us part of the dose because we do not have 
enough money and asks us to return for the other half when we have got money, can 
anyone go back to the dispensary to pay for the remaining dose when one already 
feels ok with the first dose?” 
 
Other health worker practices that might hinder uptake of AL were related to the use 
of SP, a drug that two of the health workers considered as still effective. One primary 
health worker said the following in relation to SP: “SP is one of the best malaria 
drugs I have ever come across- fast acting and very easy regime, and sometimes we 
have to wonder why the replacement occurred too soon.” Asked why they continue 
dispensing SP despite the change to AL, health workers cited shortage of AL, so they 
administered SP to stop patients from using drugs from the shops. A health worker 
had this to say:  “We cannot leave the patient untreated because if we do, they will 
use painkillers or ineffective anti-malarials from the local shops and that will 
eventually lead to severe malaria….” The suggestion that SP and AQ are effective 
could mean that the health workers received poor training during the switch to AL, 
given the widespread knowledge that both are now ineffective. This was substantiated 
by the fact that even after the training, some health workers were still in doubt about 
what exactly they should tell patients regarding the correct dose schedule for AL. One 
health worker expressed her doubts in the following statement: “…we simply tell them 
to take drugs everyday at 9am and at 9pm. I do not know if we are doing the right 
thing….” Other reasons mentioned by health workers for administering SP included 
their perception that some patients are too poor to buy AL from private pharmacies 
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There was also a rush by health workers to get rid of AL stocks that were supplied 
when close to the expiry dates. In order to avoid wastage occasioned by expiry, some 
health workers issued AL to cases that should have been treated with non-
antimalarials. A health manager commented:  “Often AL supplied to health facilities 
have short shelf-life and the health workers struggle to give them out in the shortest 
time possible to beat the expiry date. This has lead to their haphazard use including 
being given to patients who should be treated with antibiotics or painkillers....” The 
administration of this drug unnecessarily may have lead to complaints of „over-
treatment‟ by the community. Overtreatment, to the community, meant that patients 
were being given unnecessary drugs and some of them said they never finished their 
doses.  
  
At least two health workers delegated part or all their duties to Community Health 
Workers (CHW), who were also expected to advise patients on drug dosages. The 
CHWs were neither trained on the new malaria treatment guidelines nor had any 
formal medical training. These attributes could make critical health information about 
adherence and the need to change policies unavailable to patients.  
 
4.4.4 Inaccurate information and resistance from the community 
A clear and widespread finding, which could have had an effect in the uptake of AL, 
was the confusion created by the different advertisements about different drugs over 
the radio. This led to poor knowledge about drug changes in general and AL in 
particular. This was expressed by a young man in the following statement:  “…the 
dispensary gave my wife what it said were the newest malaria drugs but the 
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confusing.” Whereas there is limited information about the recommended anti-
malarial, the expectation among community members was that the „latest‟ drug should 
be the same at the shops and at the dispensary. Confusion arose on the realisation that 
the „latest‟ malaria drugs from the dispensary are different from the „latest‟ in the 
shops.  
 
The study participants also expressed dissatisfaction with presumptive treatment, 
which they claimed, was of poor quality. For example, in an FGD, a young mother 
said, “...he [health worker] just looks at the baby and prescribes treatment. How does 
he know what anyone is suffering from without tests?” Others in at least six FGDs 
claimed that they avoided the dispensary and instead delayed treatment to travel to the 
hospital where they were assured of the tests. The majority of study participants also 
said that they would adhere to their medication if they were tested and told exactly 
what they were suffering from. With presumptive treatment, study participants feared 
that they were not being given the right medication for their illnesses. 
 
Community culture also played a role in the evident poor reception to AL. Culture 
was manifest in the use of traditional methods of cure as well as in the use of familiar 
drugs. In the study area, the use of herbs to treat malaria or any other illness is a well-
established cultural practice that a policy change per se may not change.  A middle-
aged man reported that: “This [herbs] was the medicine of our grandparents and 
fathers, it served them well, so I do not see why we should not use it to treat malaria. 
Even „experts‟ are using these herbs these days...” Men, as custodians of the 
community culture, showed more preference for the use of herbs than women. Most 
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give more credence to conventional medicine. Nevertheless, a section of women also 
observed that herbs could enhance quick recovery when used alongside dispensary 
drugs. A young mother said: “Often we go to the dispensary but when we come home 
we feel like something is missing… that treatment is incomplete unless we use herbs 
alongside dispensary medicine….We cannot explain it.” Part of the reason why this 
happens is the belief in witchcraft as a cause of illness that is often treated with rituals 
involving herbs. But most women in the FGDs admitted that herbs often fail to treat 
malaria and that they used herbs only when there was no money or when the facility 
was closed. Herbs were also a cost-saving strategy: “We do not like to use the herbs 
but sometimes we have no alternative other than get herbs to treat adults and older 
children just in case they work and money that could have been spent in drugs is used 
to buy food for all household members.”  
 
Herbs alone were not the only aspect of community culture that could have limited 
take-up of the new policy. There were also drugs such as CQ and SP that had been 
domesticated and seemingly curtailed use of AL, as explained by one man in an FGD: 
“…I prefer the older drugs. I do not like the new drug because of many tablets and 
the fact that patients who use it never recover. …I think there should be a warning on 
the [AL] package that it may not cure malaria the same way it is done to warn 
smokers against cigarette consumption.”  Domestication of a drug means full 
acceptance of a drug that forms part of a community‟s material and treatment culture.  
 
4.4.5 Successful drug advertisements from the private sector  
Interview and FGD data appeared to show a positive relationship between the level of 
knowledge about a drug and the length of time it was advertised or stayed in the 
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of its long stay in the market for over four decades. Drugs such as panadol and 
maramoja were also better known because they have had sustained advertisement 
over a long time.  Moreover, private drug companies advertised their products through 
the same communication channels used by AL adverts. This added to the confusion in 
the community over which drug to use because the advertisements for competing 
drugs stretched much longer and over-shadowed communication about AL.  
The other problem identified from study participants was that the manner in which 
companies advertised their drugs did not consider the literacy skills and culture of the 
population. Words, which had several meanings for the community, were not clarified 
in the advertisements. This left community members guessing what the messages 
meant in terms of treatment for malaria. For example, the Swahili word „homa‟ refers 
to different types of ailments among members of the community under study. There 
are „homa ya malaria‟ (malaria infection), „homa ya mafua‟ (colds and flu) and „homa 
ya tumbo‟ (abdominal discomfort). But the messages passed during advertisements 
about medicine for homa left the public uninformed about which „homa‟ was being 
identified. In the end, a drug which should be used for alleviating symptoms from 
colds or flu, was also used in treating malaria. Following the confusion, a health 
worker had this to say: “In this community, the word „homa‟ means different illnesses 
including common cold, stomach upset and malaria. Unless these are clarified in the 
advertisement for drugs, the locals will continue using painkillers in treating 
malaria....” 
4.4.6 Summary 
The change of malaria treatment policy from SP to AL in Kenya was protracted and 
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vested interests either distrusted the government on the policy change to AL or feared 
that the replacement of SP would deny them business opportunities.  After the policy 
change was given a go-ahead by the government, difficulties were then experienced 
during implementation because beneficiaries were not adequately mobilised and 
informed about the change of malaria treatment policy. The DHMT lacked resources 
with which to pass information about the policy change to the entire district. Health 
managers and providers, as implementers of the new treatment policy, also had 
misgivings about the change to AL partly because they had limited knowledge about 
the choice of AL over other ACTs or were likely influenced by the PSK.  Part of the 
problem for the poor outcomes in the policy change was the failure of the 
communication strategy to involve multiple channels, in addition to the media. 
Secondly, actors like PHOs and local authorities who could have been crucial to the 
policy change were uninvolved. Health workers also did not fully play their roles as 
expected in explaining to patients about the drug change from SP to AL and advising 
them to change to AL and the need for adherence. Besides, some of the health 
workers continued dispensing SP, which added to the confusion of the public 
regarding the drugs in use. The confusion also came because of competing 
advertisements from private drug companies. Figure 7 summarises the key 
weaknesses of policy communication during the change of treatment policy from SP 
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-Minimal or no knowledge of drug changes 
-No knowledge of AL as recommended drug 
-Preference for non-recommended or ineffective drugs 
-Proliferation of non-recommended or ineffective drugs 
-Pessimism about the policy change 
-Continued dispensing of moribund drugs (SP, AQ) 
 
National level factors 
-Prior opposition to AL 
- Poor communication 
strategies with communities 
-Lack of support for DHMTs 
to engage communities 
-Lack of monitoring and 
feedback on policy 
implementation 
 
District level factors 
-Provider behaviours (relations 
with patient; use of SP &AQ) 
-Poor linkage between district 
and community 
-Inadequate training 
-Inadequate resources (staff & 
communication) 
-Un-mobilised actors 
Community level factors 
-Uncertainties on efficacy of AL  
- Confusion over numerous malaria 
drugs 
-Lack of access (information & drugs) 
-Lack of confidence in health workers 
-Prior experience with malaria 
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This chapter reflects on the findings presented in chapter four and compares them 
with wider literature on policy and communication in terms of the following:  impact 
of communication strategies, treatment seeking behavior, perception about health 
interventions, access to health information, role of health workers in policy 
implementation and community relations with the government. The chapter ends by 
giving recommendations about best approaches in implementing policy changes in 1
st
-
line treatment for uncomplicated malaria.  
 
5.2 Discussion of implementation experiences 
 
The discussion in this section is categorised into sub-headings reflecting major areas 
of finding in this study. 
 
a. Communication strategies 
The communication strategies adopted during the policy change to AL were meant to 
accomplish two objectives. The first was to educate the public about the need to 
change from using SP and other ineffective antimalarials to accept the use of AL. 
Secondly, to help dispel any misconceptions about AL. However, the findings suggest 
that these objectives were largely unmet owing to inherent weaknesses in the design 
and implementation of the strategies used. There was substantial failure in the health 
worker training, yet changing treatment seeking behaviour, including encouraging the 
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2003, Lettenmaier, 2003). Effective communication would have created awareness 
about AL and its benefits as well as inspiring confidence of patients in health workers 
and facilitating take-up of the drug. In contrast, inadequate policy communication can 
be a barrier to successful policy implementation as suggested by the findings. A 
recent study in Uganda about the use of drugs and perceived efficacy also observed 
that use of drugs is driven by the amount of information coming to policy 
beneficiaries over a period of time (Rutebemberwa et al., 2009). The delivery of 
health information should involve multiple methods (Eriksen et al., 2005) because 
reliance on a single tool to engage the public over a short duration did not seem to 
achieve the desired results in Kenya. These need to be supported by prolonged public 
engagement during health policy changes  as people may slowly pick up new health 
interventions because of the existence of a grace period of information processing 
(Alaii et al., 2003b).  
 
The central role of the community to the success of new drug policies has been 
emphasised by a number of authors (Williams et al., 1999, Hausmann-Muela et al., 
2003, Muga and Jenkins, 2008). However, the poor engagement with the community 
during the policy change, as demonstrated in the findings, suggest that the change to 
AL was substantially driven by drug efficacy considerations. Although the community 
expressed discomfort with AL and the changes in malaria drugs generally, it would be 
premature to conclude that there was an aversion to the use of AL as an anti-malarial. 
On the contrary, there were indications from interview and FGD data that uptake of 
AL would improve if there were concerted efforts to inform the public about the drug 
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not always true that demand for an intervention always transforms into its utilisation 
(Alaii et al., 2003a) 
 
b. Perceptions about AL  
The findings suggest that user perceptions create the difference between demand and 
utilisation of an intervention, as positive perceptions encourage uptake and use of an 
intervention and vice-versa. The noted perceptions about AL were partly driven by the 
fear that when one got infected with „strong‟ malaria as a result of using „strong‟ 
drugs against „weak‟ malaria, then one might not get cured. The categorisation of new 
drugs as either weak or strong by the community bears some similarities as well as 
slight differences with findings from other settings. The study community labelled AL 
as either weak or strong depending on how it was taken, who took it or who did not, 
and the number of tablets. In Tanzania, SP was considered as strong based on its side 
effects and the fewer number of tablets (Nsimba, 2006a). In Uganda, people had 
misconceptions about SP during its inception (Mbonye et al., 2006b). Similarly, in a 
study about community reactions to ITNs, people were reluctant to use ITNs because 
they feared that the chemicals in ITNs would affect their fertility (Alaii et al., 2003b). 
Generally, any negative views can lead to a community‟s reluctance to accept new 
health policies while positive views, as reported in west Africa about immunisation, 
can facilitate uptake of new policies (Leach and Fairhead, 2008).  
 
c. Culture and uptake of AL 
The study community‟s reluctance to adapt to new health interventions was 
influenced by factors beyond poor provision of information and local perceptions, 
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get used to drugs about which they have had information for a long time 
(Rutebemberwa et al., 2009). The feeling was that people in the study district were 
reluctant to move away from the use of familiar drugs with which they felt „safe‟, 
especially in a context where there was scarcity of information to help in the transition 
from older acculturated drugs to new ones. Wider experiences indicate that treatment 
behaviours are difficult to change (Mwenesi et al., 1995, Kreuter and McClure, 2004, 
Rutebemberwa et al., 2009), which partly explains why there was a lot of information 
from study participants throughout the study district about CQ being the best drug for 
malaria. The drug, which lasted many years as the 1
st
-line treatment for
uncomplicated malaria in most of the Sub-Saharan Africa, had to be withdrawn from 
the market to stop its consumption long after it developed parasite resistance.   
There were also wider cultural influences in the uptake of AL in the study site. The 
cultural and resource dominance of men ensured their decisions regarding when, 
where and how malaria was treated. Their preference for informal sector drugs was 
negated by women‟s preference for the formal health sector. The majority at formal 
health facilities are usually women, a factor attributable to higher disease rates among 
women and children, and women‟s preference for formal sector treatment 
(McCombie, 1996). Thus getting effective treatment to the community went beyond 
availability of resources within a household to include who, between a husband and 
wife, controlled resources.  
The dominant belief in witchcraft among the Duruma people (MOH-Kenya, 2006) 
was a cultural dimension that could have influenced poor reception to AL. The belief 
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medicine-men to ward off potential harm to a household (MOH-Kenya, 2001). Many 
of the study participants reported using herbs alongside modern drugs from the 
dispensary to treat illnesses. The use of both conventional and traditional methods of 
treatment indicates the uncertainty that many members of the community have over 
the exact cause of illness. Illness, in the community understanding, may be caused by 
pathogens or by witchcraft, but both often have similar symptom presentations. 
Severe malaria presenting as convulsion, for instance, is often regarded as the result of 
evil spirits (Hausmann-Muela et al., 2003). Such beliefs were found important in 
relation to acceptance of new policies in particular and in treatment seeking generally. 
These cultural influences on treatment seeking and illness outcomes have been 
documented by a number of authors (Mwenesi et al., 1995, Alaii et al., 2003a, Alaii et 
al., 2003b, Hausmann-Muela et al., 2003, Kreuter and McClure, 2004) . 
 
d. Treatment seeking from the informal sector  
The informal sector in Kenya was observed to offer a large pool of drugs, whose 
continued use seemed to limit uptake of AL. The influx results from a free market 
economy. The failure by the government to implement strict regulation in the drug 
market and develop a phase-out plan for non-recommended antimalarials is also to 
blame. The convenience of the informal sector fuels widespread self-treatment for 
malaria, particularly among adults, a tendency that is motivated by the notion that 
malaria in adults poses limited threat (Mbonye et al., 2006b). Self-treatment also 
results from lack of confidence in new drugs (McCombie, 2002), a fact that was 
spotlighted in this study through community attitudes and perceptions about AL. The 
reported low uptake of AL (Wasunna et al., 2008) means that malaria patients 
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shopkeepers. This leads to inappropriate use of pharmaceuticals and raises concerns 
over cost implications for the buyer, side effects and development of drug resistant 
parasites (McCombie, 2002, Attaran et al., 2004, Bosman and Mendis, 2007). 
Besides, patients who fail to recover from using the ineffective drugs often have to 
meet higher costs for treatment that may be beyond the reach of poor households.  
 
The availability and use of the informal sector drugs also caused confusion to the 
public, especially whenever new drugs were released into the sector and the 
shopkeepers made it known to potential buyers of the presence of the „latest‟ 
antimalarial. For lack of accurate information, the study community could not 
understand the difference between the shopkeeper‟s „latest‟ drug and the „new‟ one at 
the dispensary. This was particularly made difficult by advertisements of the informal 
sector drugs through the radio in a language that implied that the drugs were effective 
against malaria. Moreover, AL was not an over-the-counter drug at the time of the 
study, and could only be accessed through public health facilities. By confining AL to 
the formal public sector where the minority seek treatment, it was unrealistic for most 
people to suddenly change treatment seeking from the informal sector to the poorly 
accessed public sector.   
 
The malaria treatment guidelines indicated that AL was supplied only to public health 
facilities until 2009, when it was supposed to be released to the formal private sector 
and finally to the informal sector, as well (MOH-Kenya, 2006). This was expected to 
be at a reduced cost following a 95% subsidy by the Affordable Medicines Facility-
malaria (AMF-m) initiative (Laxminarayan and Gelband, 2009). The strategy was 
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artemisinin monotherapies. The problem at the time of this study was that most people 
did not know that AL was the officially recommended and most effective 1
st
-line 
treatment for uncomplicated malaria. Besides, widespread use of ACT to 
presumptively treat fevers in the retail sector would create unnecessary drug pressure 
for resistance in Kenya (Noor et al., 2009, Snow et al., 2009). 
 
e. Access to health information  
The main channels (radio and posters) that were used to pass information about the 
policy change at the community level did not entirely benefit women. Study 
participants said that most radios were owned by men and some health workers 
pointed out that men were generally more literate than women in the study district and 
therefore had better access to posters that were used as an alternative AL 
communication channel. This symbolised poor investment in IEC that often led to 
inefficiency in the delivery of care in the primary health services (Mozumder and 
Marathe, 2007). To achieve good results,  health communication should endeavour to 
meet the preferences of the target group in order to increase access to information 
(Kreuter and McClure, 2004). The access factors to be considered when passing 
health information include linguistic and physical access (Eng et al., 1998, Kreuter 
and McClure, 2004, Claasen-Veldsman and Snyman, 2005)  as well as affordability 
(Emmanuel, undated). Information passed through channels requiring literacy, for 
instance, generally have little effect on a largely illiterate community. Also, 
communication through television or mobile telephones when the target audience 
have no access to such gadgets or cannot afford them is equally ineffective. A better 
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methods, with the former being in recognition of the oral nature of African cultures 
(Kreuter and McClure, 2004).   
 
g. Health providers 
The oral and interpersonal approach to health communication would have been 
enhanced if health workers engaged their patients in dialogue about the policy change. 
Information about change of drugs, reasons for the change, the need to adapt to the 
change as well as the importance of adhering to the dosage, should ideally, have come 
from health workers. The community regarded health workers as health experts and 
health information from experts is better received than that from ordinary persons 
(Kreuter and McClure, 2004). Basic health information was necessary to avoid the 
scenario where, among other things, the community interpreted policy change as a 
means of profiteering. Furthermore, failure to explain to patients the need for 
adherence most likely compounded the problem of patients not completing drug doses 
because AL presented with a much more complex dosage than SP.  
 
Health outcomes depend a lot on the discussion between a patient and a doctor (Roter 
and Hall, 1989, Gilson, 2007). Unfortunately, there is ample literature (Inui and 
Carter, 1985, Roter and Hall, 1989, Roter and Hall, 1991, Moore et al., 2000, Gilson, 
2007) to support claims of negative relationships that patients have with health 
workers. The findings suggested that health workers failed to recognise and utilise 
their power to pass health knowledge to their patients and the community at large. 
Such omissions existed despite the fact that positive provider communication 
behaviours are positively related to patients' perceptions of providers‟ competence 
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patients, especially in remote settings, were such that the provider expected patients to 
do as told without questions. The only communications that seemed to exist were top-
down instructions given by health workers to patients. Such top-down instructions are 
akin to an authoritarian relationship between providers and patients, something, which 
has been attributed to socialisation within similarly authoritarian settings (Gilson, 
2007).   
 
Other important aspects of provider behaviour which had a negative impact on the 
outcomes of policy communication, included administration of SP instead of AL, the 
perception that SP is effective, delegating work to unqualified staff and informal 
charges and/or corruption allegations.  The continued issuance of SP and AQ at health 
facilities might have convinced patients that the drugs were still viable for malaria 
treatment. The two drugs are easily available in local shops and sick people or care-
takers probably found it convenient and cost-saving to purchase the drugs at the shops 
rather than take time to visit a health facility for the same drugs.  Health workers also 
administered SP because of AL stock-outs and because some patients preferred the 
other antimalarials (Wasunna et al., 2008, Kangwana et al., 2009). Although the 
perception of health workers regarding the superiority of AL was never in doubt, 
some of them believed that it had a very complex dosage pattern and imposed a high 
cost on patients. In the absence of AL, the concern for costs also made health workers 
to administer SP in the belief that a very poor person would not be able to purchase 
AL even when prescribed.  
 
Organisation of health care delivery and gaps in the system also contributed to poor 
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findings suggested that the provision of presumptive treatment in most primary health 
facilities in Kenya undermined patient confidence in health workers‟ ability to offer 
quality treatment. To avoid such negative patient behaviour, the providers should have 
explained the reason for presumptive treatment to the patients. A study in Tanzania 
also showed that patients preferred being tested and that testing inspired confidence in 
the diagnosis of their illnesses (Mwisongo, 2007). Erosion of confidence in providers‟ 
ability to treat also resulted from the delegation to unqualified staff of medical duties. 
This may not be entirely odd given the severe staff shortages in many rural health 
facilities in Kenya and the usually large numbers of patients who must be served in 
just a few hours. Staff shortages can run to about 50% in facilities in rural areas 
(Adano, 2008, MOH-Kenya, 2009). There were also the strong allegations of 
corruption against health workers. Although under-the-counter charges are a feature 
in many health facilities in low and middle income countries (McIntyre et al., 2009), 
they often cast any health intervention effort in a negative light, and so generate 
strong mistrust of government health care initiatives.  
h. Distrust in government initiatives
Mistrust of the introduction of AL was felt nationally when the initiative to move 
from SP to AL was opposed by the Pharmaceutical Society of Kenya (Amin et al., 
2007). The PSK draws some of its membership from medical professionals who, as 
members of PSK were thought to oppose the change to AL. On the other hand, as 
members in health care management, they were supposed to ensure successful policy 
implementation. These conflicting roles could have compromised the policy change. 
The community also viewed the change from SP with suspicion believing that it was 











86 | P a g e  
 
unfounded, the wider socio-economic and political context appears to have shaped 
public attitudes to this government initiative. The study was undertaken during serious 
famine as observed in the study district and amidst local and international reports of 
grand corruption in the government (Wrong, 2009). An environment of mistrust 
generally makes it difficult to successfully implement health interventions because the 




This study suggests that the change of 1
st
 line treatment for uncomplicated malaria 
from SP to AL in Kenya was compromised by design and implementation problems 
in the accompanying policy communication strategies. In the study district there was 
very limited knowledge of AL and of the policy change. The findings suggest that the 
population in the district would value an effective malaria drug but did not yet 
understand AL to be that drug at the time of the study. This understanding gap not 
only reflects policy communication failures but also a wider lack of confidence in the 
broader health system. In societies like Kenya where pluralistic practices of health 
seeking are common, information passed through appropriate channels of 
communication becomes vital to changing practices, perceptions and behaviours so as 
to improve utilisation of new drugs among groups and individuals. In sensitive 
matters like change of drugs, it is necessary to have consistency in messages passed to 
the public through multiple channels. The channels used should emphasise 
interpersonal and oral communication to avoid the confusions that act as barriers to 
acceptance and use of new treatment policies. Interpersonal communication enables 
active engagement with the source of the information and also avoids the confusion 
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AL, was used. With the change from SP to AL, the communication strategies were 
expected raise to awareness and usage of AL but this was not the case because the use 
of the print and electronic media alone was limited in scope and in terms of access to 
health information. The result has been a rural public struggling to find a better drug 
to treat malaria, often moving from one drug to the next, and back and forth between 
modern and traditional methods, or a mixture of all these, in a trial and error fashion. 
This kind of behaviour symbolises the uncertainties about drugs that communities 
face in their quest to find reprieve from malaria. As things stand, it is far from clear 
that prompt and effective malaria treatment will be achieved soon especially in remote 
rural communities where malaria is still managed at home, in large measure using 
traditional methods and ineffective drugs. What is encouraging is that there is no 
evidence of rejection of the AL intervention altogether but there are important 






The recommendations presented here are derived from the findings of the study and 
are discussed in line with the recommendations of the United States Agency for 
International Development (USAID), Strategic Objective 5 that gives an 
implementation framework for changing treatment policy to ACTs. The document 
provides “guidance to countries on the actions that need to be taken when considering 
changing  national policies for the first-line treatment for malaria to an ACT 
consistent with WHO recommendations as well as implementing the change,” 
(USAID, 2005):1). The framework for implementation has 3 components, namely: 
Technical, Operational, and Monitoring and Evaluation. Where possible, the study 
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The technical component deals with matters related to three essential areas of ACT 
policy, namely: registration of ACTs in the country and changing its treatment policy. 
The other is to determine whether regulations on prescribing, dispensing, distribution 
and sale of ACTs in the country are consistent with the adopted policy. In detail, these 
include revision of drug regulation, review of the Essential Medicines List (EML), 
review and dissemination of treatment guidelines, training and supervision of health 
workers consistent with the new guidelines and IEC targeting the community. 
Operational considerations address the development of a phase-out plan for removing 
non-recommended drugs from the health system. Monitoring and Evaluation involves 
plans to track implementation progress and performance with respect to defined goals 
and objectives, how performance will be monitored and sources of information for 
monitoring implementation. Table 3 is a summary of key recommendations: 
 
Table 3: A summary of some key recommendations 
Problem Recommended solution 
1. Problems with provider attitudes and 
practices 
(a) Unfamiliarity with dispensing AL 
(b) Continued use of SP 
(c) Poor provider-patient relations 
1.Emphasis on training health workers on technical and 
communication skills by the MOH 
2. Supervision of peripheral facilities at district level by the DHMT 
3. An all inclusive training for all key staff including public health 
officers 
2. Presence of other anti-malarials and unclear  
messages over efficacy of AL 
1. Development of a phase-out programme by the MOH and 
relevant arms of  the government 
2. Elaborate public education including interpersonal 
communication and media, peer education to be conducted by the 
MOH through PHOs at village level. 
3. Clear and culturally sensitive IEC language should developed in 
consultation with policy makers, health workers and the 
community  
3. Lack of access to information and drugs in 
public facilities 
1. Design health information materials with physical access 
(availability), semantic access (literacy) and affordability in mind. 
2. Use of localised drug delivery mechanisms such as community 
health workers 
4. Loss of confidence in health workers because 
of presumptive treatment 
 
1. The MOH to supply RDTs to primary facilities 
2. Health workers at community level should educate the public on 
the need for presumptive treatment 
5. Poorly implemented communication strategy 1. Need for impact assessment of IECs by independent evaluators 
2. Monitoring and evaluation component in the policy change 
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Technical Considerations 
Although this study did not directly examine the regulations governing ACT use in 
Kenya, it provides clear evidence of problems in the implementation of the 
established guidelines and in the practice of prescribing, dispensing, distribution and 
sale of ACTs.  
 
The first problem involves training and supervision of health workers during policy 
change. Adequate training for health workers is required to equip them with the 
necessary skills regarding the new treatment policy. Although the Kenyan government 
endeavoured to train health workers during the change to AL, the study findings 
suggested that some health workers in the study district felt the training was 
inadequate because the time allocated was too short to enable trainees to get to grips 
with the complexities of the new treatment guidelines.  Perhaps as a result, the 
findings provided information that, whatever training was actually received, either did 
not cover all relevant issues or was not translated into practice. Training should, for 
example, emphasise that health workers should not dispense SP or AQ to any patient 
who presents with malaria fever.  In addition, training for drug policy changes must 
not only involve equipping health workers with treatment skills but also skills for 
communicating with patients, because communication is an important component in 
treatment and adherence. Engaging health workers in policy communication should 
also include encouraging them to pass key messages concerning the policy change to 
their patients as well as encouraging patients to raise any concerns or questions and 
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Training can also be supplemented by supervision of health workers. Supervision of 
health workers and appraisals with feedback are effective ways to improve health 
worker performance in terms of adherence to the new malaria treatment guidelines 
(Rowe et al., 2005). The findings here also suggest that supervision and audits could 
be supported with in-service training or refresher courses to keep health workers 
abreast of new developments or areas that need to be strengthened during the policy 
implementation. Health workers are likely to forget some of the things on which they 
have been trained (USAID, 2005).   
 
Finally, participation in training should be thought through carefully, as these findings 
show that key staff who interact with the larger community were not trained. Future 
trainings should involve consultation with health managers at the district level to help 
in identifying key staff for training for the policy change instead of using top-down 
approaches. The top-down approaches may lack appropriate information regarding the 
most strategic personnel to be trained during treatment policy changes. There should 
also be consistency in the messages passed in the training guidelines. For instance, the 
training guidelines were clear that public health officers (PHOs) were to be trained on 
the policy change. But at the same time, the guidelines emphasised that those to be 
trained were personnel directly involved with dispensing medicine, which excludes 
PHOs. This inconsistency may have led health managers to leave out PHOs who 
could have been an excellent link with the wider community. 
 
Operational considerations 
In Kenya, malaria control continues to be a vertically controlled programme under the 
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ministry a central steering role in developing strategies that would ensure that health 
policies are successfully implemented. A key problem in the take-up of AL by the 
public is the confusion created by several anti-malarials in the market whose sales and 
further confusion are facilitated by the media and the ministry has a central role to 
play in regulating circulation of these drugs. It is difficult to ban these drugs as it 
raises several complexities (USAID, 2005) because manufacturers are likely to seek 
legal redress. There is also the potential for job losses which may translate into some 
levels of social unrest. This means that a phase-out programme should be developed 
that would include rescheduling some of the drugs to a prescription only. This, 
according to (USAID, 2005) should reduce their demand over time. Part of the phase-
out plan should include a process to monitor the language used by drug advertisers to 
ensure that they do not confuse and lead the public into consuming ineffective malaria 
drugs. And non-malaria drugs that are often mistaken for anti-malarials by the public 
should be clearly labelled on the packages that they do not cure malaria and a caveat 
after their advertisements to that effect.  
In addition, future drug policy changes require an elaborate public education 
programme designed with community concerns and practices in mind. The findings 
suggest that in phasing out one drug and introducing a new one, interpersonal 
communication alongside IEC materials can be used to establish a conducive 
environment for policy implementation at the community level. This can be achieved 
by engaging, for example, PHOs, the local authority and women groups in advocacy 
for the new policy.  Simultaneously, outreach programmes involving peer educators 
from social groups such as youth groups and women groups should be encouraged to 
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malaria.  A study about role of IEC on HIV/AIDS control has shown that critical 
information can be passed through booklets, radio and word of mouth as well as 
audio-visuals (Aggleton et al., 2005).  
 
It is also important that the language involved in the IEC should be clear and 
culturally sensitive because words used in advertisements that have many meanings in 
local culture are most often misunderstood when used without further clarification. 
Given the experience in the study site as discussed here, all forms and strategies of 
communication with the public should focus on the following priority areas:  
 Clarify to the community about policy directives on free treatment for 
malaria so that people are empowered to demand for their rights. 
 Clarify about drug changes, that is, why the changes have occurred, a 
change from which drug to which drug, and emphasise the need to adhere 
to the dosage, and why presumptive treatment sometimes result in issuance 
of various types of drugs. 
 Enlighten the public about the difference between the recommended drugs 
and drugs at the shops. 
 Encourage prompt and effective treatment at the earliest onset of illness. 
 
Another important finding to note in relation to policy communication is that there 
were particular problems in accessing information relating to the change in treatment 
policy especially among the primary care-takers, that is, the women, who were the 
main target population with the IEC strategies. Access to health information should be 
designed along the lines of physical and semantic access, and affordability (Claasen-
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all categories of the population can be reached with key messages. Women were 
particularly disadvantaged by the IEC materials because they are less likely than men 
to own radios, they control less resources and form the bulk of illiterate members of 
society. They are, therefore, better off accessing health information through 
interpersonal means. 
 
The last strategies suggested by these findings to support the phase out of one drug 
and use of a new one focus on the need to improve malaria treatment in the public 
sector specifically (Yeung et al., 2008). Only the public sector spreads across the 
country. To improve access to it, one option would be to use localised drug delivery 
mechanisms such as Community Health Workers (CHWs) specifically trained to 
dispense AL in order to address problems of access to effective health services related 
to availability of moribund antimalarials at local shops, distance to facilities, long 
queues and opening hours at rural health facilities. The findings show that there are 
CHWs already administering AL to patients in remote dispensaries and in the absence 
of the nurse in-charge, are often left to run the facility on their own. Cases like this 
can be studied and built on to ensure that quality standards are not compromised 
especially now that AL would be soon available to informal drug vendors according 
to the treatment guidelines. Trained CHWs would be accessible at all time and may 
significantly reduce buying drugs from untrained shopkeepers who may be more after 
profits rather than ensuring that a patient gets the correct dosage of the recommended 
anti-malarial. Shopkeeper training programmes may also be undertaken to improve 
AL coverage and adherence. Improved access to effective drugs could also help in 
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The findings suggest that patients probably prefer to be diagnosed through tests before 
treatment instead of being treated presumptively, because the approach makes patients 
lose confidence in health workers (Mwisongo, 2007). Loss of confidence in health 
workers is a barrier to policy communication and lowers uptake of AL since patients 
are not sure whether they have been given the right drugs for their illnesses. The 
supply of Rapid Diagnostic Test (RDT) kits to primary health facilities might address 
this problem, but would require an initial study on the feasibility and sustainability of 
the approach. 
 
The WHO confirms that parasite-based diagnosis can guarantee appropriate use of AL 
and save costs. RDTs are cost-effective in most parts of Africa (Rolland et al., 2006, 
Shillcutt et al., 2008) and even at a high prevalence levels of 90%, parasitic diagnosis 
with RDT is likely to cost somewhat more than the presumptive approach (Rolland et 
al., 2006). However, the cost-effectiveness may also depend on the trust and 
confidence that the provider and the patient have on the results (Williams et al., 2008). 
Apart from RDTs, there should be a reduction on pill-count to eliminate complaints 
over the number of tablets and increase adherence. 
 
In any communication strategy, it is important that appropriate steps are taken at an 
early stage to give the public confidence in the drug of choice for the treatment of 
uncomplicated malaria, such as AL. In doing so, the role of cultural practices and the 
influence of global interests in the use of AL should be noted in the design of 
communication strategies. Conservative cultures do not always accept changes very 
quickly. Effective change in behaviour would require sustained flow of information to 
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(Kreuter and McClure, 2004). The subsequent change of behaviour would recognise 
and use AL as the appropriate anti-malarial for uncomplicated illness.  
 
Monitoring and Evaluation 
The IEC strategy was rolled out without impact assessment and did not empower the 
public with information about the new treatment policy. In addition, it was clear that 
not all health workers acknowledged the wisdom behind the change of treatment 
policy to AL and singled out the inconvenience of the drug‟s complex dosage as a key 
factor. The IEC strategies cannot be implemented in a vacuum but should have clearly 
set and achievable goals and a mechanism for impact assessment (Aggleton et al., 
2005). The impact assessment report should use feedback from the community to 
redesign IEC materials and approaches.  
 
With a monitoring and evaluation component in the policy change, it could have been 
possible, for example, to pick out negative health worker perceptions on AL and 
provide feedback for further training interventions. Health worker performance in 
terms of adherence to treatment guidelines for AL could be audited through malaria 
patients who may be asked basic questions on what kind of drugs they have been 
given, the dosing schedule and how important it is to the patients to adhere to the 
dosage. These are some of the problem issues at the community level that have 
contributed to low use of AL in the study area. Because community awareness about 
the new treatment policy is significantly poor, monitoring and evaluation could have 
been used to track AL policy implementation progress at the community level by 
assessing the level of community awareness and use of the new treatment policy, and 
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Future policy communication, in order to benefit the community, should pay 
significant attention to training for health personnel. The training should aim at not 
only equip health staff with treatment skills but also train them in how best to open 
dialogue with their patients. Training should also be supported with adequate 
supervision of health personnel to facilitate adherence to policy guidelines alongside a 
viable phase-out programme to limit impact of un-recommended drugs in the health 
system. The language used in communicating with the community should be 
unambiguous and culturally sensitive. Broader IEC strategies should be undertaken 
simultaneously with interpersonal communication to improve access to health 
information. All these efforts should have a mechanism for monitoring and evaluation 
of policy implementation. 
 
Finally, further research is required with quantitative methodologies to ascertain the 
level of awareness about first-line drug for uncomplicated malaria, knowledge of AL 
and drug utilisation patterns at a national scale. Also required at the national level is 
research on the communication strategies that will be most effective in reaching and 
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APPENDICES 
Appendix A: QUESTION GUIDES 
A. In-depth interviews: District and primary health managers
1. What factors influence malaria control in the district?
2. How has the switch from SP to ACT influenced malaria control in the district?
3. What are the health workers views of ACT? To what extent has the public accepted
ACTs?
4. How successful is the move from SP to ACT in the district?
5. What could be the possible role of health service managers/health workers in influencing
the public to accept recommended drugs?
6. How was the public engaged during the change from SP to ACT? What communication
channels were used? Who was involved? Who was targeted?
7. How have the communication channels influenced use of ACT in the community?
B. Patient narratives
1. Are you aware of what you are suffering from?
2. Tell me about your illness: how it started; what you feel caused it; the kinds of treatment
options you have taken; and why?
3. When you suffer from malaria, what drugs do you usually use? Do you have a specific
preference? Why?
4. Why do some people use different drugs to treat malaria?
5. Are you aware of any recent changes in malaria drugs? How important is this change of
drugs to you?
6. How did you find out about the new malaria drug? How important was this information to
you? How has it influenced your choice of malaria drugs?
7. Do you consult anyone before using any malaria drugs? Who? Why?
C. In-depth interviews (community KI)
1. How would you describe the malaria situation in the village?
2. Where do malaria patients seek treatment? Why in these places?
3. What kinds of malaria drugs are used in the community? Why so many drugs?
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5. Why do malaria drugs change from time to time? How are these changes important to
you?
6. What are your views about the changes in malaria drugs?
7. Were these changes communicated to the community? How? Who was involved? Who
was targeted?
8. What was the importance of the communication? How has the communication influenced
people‟s choices of malaria drugs and/or treatment?
9. What was the role of community leaders in communicating these changes?
10. How do people in the village get information about drugs?
D. Focus group discussions
1. Where do you treat malaria in the village?  What influences choice of these treatment
sources?
2. Where do you get drugs for treating malaria? Why do you choose these sources?
3. There seems to be so many malaria drugs available within your community. Do you have
any ideas why this is so?
4. Who, in your opinion, decides which malaria drugs to use? Why?
5. Why do malaria drugs change from time to time? How are these changes important to the
community?
6. How have recent changes in malaria drugs influenced people‟s choices of treatment?
7. Were these changes communicated to the community? How did you receive information
about these changes? Who was involved in passing information? To whom?
8. What do you think would be the importance of communicating to the public about change
of malaria drugs?
9. What would you like to know about the new drug?
10. How do you feel now that the malaria drugs have been changed and you are not even
aware of it?
11. How do people in the village get information about drugs?

















Study Title: Community responses to malaria drug policy changes and the potential influence 
of communication strategies in the uptake of malaria drugs in Kenya  
 
What is the University of Cape Town? 
The University of Cape Town is a public institution of higher learning which, among other things, 
carries out health research. The kind of research that we intend to carry out is different from 
treatment as it does not involve drugs.  
 
The purpose of the study 
The purpose of our study is to understand what people have responded to malaria drug policy 
changes and how their responses have been influenced by communication strategies for the policy 
change. As you may know, their maybe a change of malaria drug but people may not know the 
reasons for the change or may not know that there has been a change of malaria drugs. We are 
trying to know what people understand of these policy changes and how they receive 
communication about the changes. 
 
Voluntary participation 
You may choose to take part in the study or not, but we would strongly encourage your 
participation because it is only through your responses that those responsible for health can best 
know how to deliver better services to you. However, there is no harm in choosing not to 
participate. Those taking part in the study and would like to withdraw can do so any time in the 
course of the study. We are neither paying any money nor supplying drugs to participants.  
 
Confidentiality and anonymity 
No one other than the researchers and our supervisors will have access to the information we will 
get from you. Besides, our research records are stored in a locked safe and in computers which are 
password protected. Our final report will not have any names such that those participating will 
remain anonymous to everyone reading the report.  
 
Benefits and Risks 
There may not be direct benefits to all individual participants, but there may be future benefits to 
entire communities if recommendations of the final report are adopted. Overall, your opinions will 
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The risks for involvement in the study are very minimal as it does not involve any invasive 
procedures such as drawing blood. However, as a participant, you may be inconvenienced because 
we will take some of your time (about 30 minutes); besides, we will be asking you some questions 
that you may feel are personal. 
 
Who sanctioned research? 
The research has been authorized by the University of Cape Town Ethics Committee. These 
bodies have scrutinized the study and confirmed that it is necessary, safe and will be carried out as 
required by ethical guidelines.  
 
Any questions…? 
You can ask any member of the research team questions that you might have (PI Tel. (+254) 
(0)722-779-456. Further questions about the study maybe directed to the Health Economics Unit, 
University of Cape Town, Anzio Rd, Observatory 7925; Cape Town, South Africa. Tel.: +27 406-
8152 
 
In case you need further clarification from the University of Cape Town, feel free to contact the 



































Study Title:  Community responses to malaria drug policy changes and the potential 
influence of communication strategies in the uptake of malaria drugs in Kenya  
 
I, ________________________________, have had the research explained to me (or have read 
through the consent information sheet). I have understood all that has been read and had my 
questions answered satisfactorily. I understand that I can withdraw from the study at any stage 
and my withdrawal will not affect health benefits due to me. 
 
Please tick one where relevant and delete appropriately: 
  Yes    No  I agree/ don’t agree to take part in this research 
 
[If the potential participant says „No‟, then terminate the consent process here] 
 
Participant’s signature: ___________________________ Date _____________ 
 
Participant’s name:      _____________________________Time ____________ 
                                                        (Capital letters only) 
 
 
I certify that I have followed all the necessary ethical procedures as stipulated in the study for 
obtaining informed consent. 
 
Investigator’s signature: _____________________________ Date ____________ 
 
Investigator’s name   :   ______________________________ Time ____________ 
                                                                (Capital letters only) 
 
 
For participants who cannot read or write: 
 
I (declare) that information on the intended research has been satisfactorily explained to me 
and I gave my consent freely based on the explanations given to me regarding the research.  
 
 
Thumbprint of the participant as named above if they are illiterate: 
_______________________ 
 
Witness’ signature:  ________________________________________     Date 
_____________ 
 
Witness’ name:       _________________________________________     Time 
_____________ 
                                   (Capital letters only) 
 
[A witness should be anyone not involved in the study and has not participated in obtaining 
informed consent]. 
 
THE PARTICIPANT SHOULD NOW BE GIVEN A SIGNED COPY TO KEEP; THANK 
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List of documents reviewed (n=6) 
1. Minutes of DHMT meetings (n=3)
a. Preparations for the launch of training workshop for primary facility health
workers
b. Report on progress of training of primary facility health workers
c. Feedback from in-charges at dispensaries and health centers regarding the new
treatment policy
2. MOH-Kenya (2009) Health care financing policy and strategy: Systems change
for universal coverage. Government of Kenya.
3. MOH-Kenya (2006) National guidelines for the diagnosis, treatment and
prevention of malaria for health workers in Kenya. Government of Kenya
4. Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, et al. (2007) The
challenges of changing national malaria drug policy to artemisinin-based
combinations in Kenya. Malar J 6: 72.
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